2024年度
2026年7月8日掲載
2024年度
英文論文
1. A Yanagisawa, T Takimoto, Y Kurahara, K Tsuyuguchi, S Yoshida, M Hirose, Y Inoue, T Arai A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy Internal Medicine 2023 Nov;63(14):2043-2047.(柳澤篤)
2. Okuma Y,Kubota K,Shimokawa M,Hashimoto K,Kawashima Y,Sakamoto T,Wakui H,Murakami S,Okishio K,Hayashihara K,Ohe Y First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial JAMA Oncology 2024 Jan;10(1):43-51.(沖塩協一)
3. Tomioka H,Miyazaki Y,Inoue Y,Egashira R,Kawamura T,Sano H,Johkoh T,Takemura T,Hisada T,Fukuoka J,Comm Japanese Resp Soc Japane Japanese clinical practice guide 2022 for hypersensitivity pneumonitis Respiratory investigation 2024 Jan;62(1):16-43.(井上義一)
4. Tamiya A Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors Respiratory investigation 2024 Jan;62(1):85-89.(田宮朗裕)
5. Nishio M,Murakami S,Kawakami H,Okishio K,Tamiya M,Kobayashi H,Fujimoto D,Sugawara S,Kozuki T,Oya Y,Izumi H,Shiroyama T,Satouchi M,Yamamoto N,Kaname S,Matsuoka D,Otake Y,Takase T,Semba T,Azuma K Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort Cancer Research Communications 2024 Jan;4(1):226-235.(沖塩協一)
6. Matsumoto K,Shiroyama T,Tamiya M,Minami T,Kinehara Y,Tamiya A,Suga Y,Kuge T,Mori M,Suzuki H,Tobita S,Ueno K,Namba Y,Tetsumoto S,Niki T,Morimura O,Osa A,Nishino K,Nagatomo I,Takeda Y,Kijima T,Kumanogoh A Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study Cancer Immunology Immunotherapy 2024 Jan;73(1):(田宮朗裕)
7. Kobayashi T,Tsuyuguchi K,Shimatani Y,Matsuda Y,Kagawa T,Takimoto T,Takeuchi N,Arai T,Inoue Y Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis Journal of Infection and Chemotherapy 2024 Jan;30(1):7-11.(小林岳彦)
8. Walsh SLF, De Backer J, Prosch H, Langs G, Calandriello L, Cottin V, Brown KK, Inoue Y, Tzilas V, Estes E; Open Source Imaging Consortium (OSIC). Towards the adoption of quantitative computed tomography in the management of interstitial lung disease European Respiratory Review 2024 Jan 31;33(171):230055.(井上義一)
9. Shibaki R,Fujimoto D,Nozawa T,Sano A,Kitamura Y,Fukuoka J,Sato Y,Kijima T,Matsumoto H,Yokoyama T,Miura S,Hata A,Tamiya M,Taniguchi Y,Sugisaka J,Furuya N,Tanaka H,Yamamoto N,Koh Y,Akamatsu H Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2024 Feb;12(2):(谷口善彦)
10. Mitsudomi T,Ito H,Okada M,Sugawara S,Shio Y,Tomii K,Okami J,Sakakura N,Kubota K,Takamochi K,Atagi S,Tsuboi M,Oizumi S,Ikeda N,Ohde Y,Ntambwe I,Mahmood J,Cai JL,Tanaka F Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816 Cancer Science 2024 Feb;115(2):540-554.(安宅信二)
11. Ikeda S,Tsuboi M,Sakai K,Misumi T,Akamatsu H,Shoda H,Sakakura N,Nakamura A,Ohde Y,Hayashi H,Okishio K,Okada M,Yoshino I,Okami J,Takahashi K,Ikeda N,Tanahashi M,Tambo Y,Saito H,Toyooka S,Inokawa H,Chen-Yoshikawa T,Yokoyama T,Okamoto T,Yanagitani N,Oki M,Takahama M,Sawa K,Tada H,Nakagawa K,Mitsudomi T,Nishio K NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study Molecular Oncology 2024 Feb;18(2):305-316.(沖塩協一)
12. Kagawa T,Kurahashi K,Seki T,Kawasaki Y,Nahara I,Takeda C,Yonekura H,Tanaka S,Kawakami K The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database Journal of Anesthesia 2024 Feb;38(1):92-97.(香川智子)
13. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Taniguchi Y,Nosaki K,Fukumitsu K,Akechi T Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer Oncologist 2024 Feb 2;29(2):e282-e289.(松田能宣)
14. Akira M,Suganuma N Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia Canadian Respiratory Journal 2024 Feb 14;2024(審良正則)
15. Kurahara Y,Okamori H,Tsuyuguchi K A Large Cavity Associated with Pulmonary Infarction Internal medicine 2024 Mar;63(20):2867-2868.(倉原優)
16. Morimoto K,Nonaka M,Yamazaki Y,Nakagawa T,Takasaki J,Tsuyuguchi K,Kitada S,Jumadilova Z,Yuen DW,Ciesielska M,Hasegawa N Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study Respiratory investigation 2024 Mar;62(2):284-290.(露口一成)
17. Molina TJ,Roden AC,Szolkowska M,Shimizu S,Moreira AL,Chalabreysse L,Besse B,de Montpr V,Marom EM,Detterback F,Girard N,Nicholson AG,Marx A International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study Lung Cancer 2024 Mar;189(清水重喜)
18. Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry. JACC-ASIA 2024 Mar;4(5):403-417.(井上義一)
19. Isobe K,Nakamura Y,Sakamoto S,Tomii K,Takimoto T,Miyazaki Y,Matsumoto M,Sugino K,Ichikado K,Moriguchi S,Yamaguchi K,Baba T,Ozasa H,Igata F,Anabuki K,Homma S,Date H,Suda T,Kishi K Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia ERJ Open Research 2024 Mar 1;10(2):(滝本宜之)
20. Richeldi L,Schiffman C,Behr J,Inoue Y,Corte TJ,Cottin V,Jenkins RG,Nathan SD,Raghu G,Walsh SLF,Jayia PK,Kamath N,Martinez FJ Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial American Journal of Respiratory and Critical Care Medicine 2024 May 1;209(9):1132-1140.(井上義一)
21. Wada T,Yoshida S,Yamamoto T,Nonaka L,Fukushima Y,Nakajima C,Suzuki Y,Imajoh M Application of Genomic Epidemiology of Pathogens to Farmed Yellowtail Fish Mycobacteriosis in Kyushu, Japan Microbes and Environments 2024;39(2):ME24011.(𠮷田志緒美)
22. Amano K,Baracos VE,Mori N,Okamura S,Yamada T,Miura T,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer Clinical Nutrition ESPEN 2024 Apr;60313-319.(松田能宣)
23. Enomoto N,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Aono Y,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Sano T,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Nakamura Y,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study Respiratory Medicine 2024 Apr;224(澄川裕充)
24. Kanemura H,Yokoyama T,Nakajima R,Nakamura A,Kuroda H,Kitamura Y,Shoda H,Mamesaya N,Miyata Y,Okamoto T,Okishio K,Oki M,Sakairi Y,Chen-Yoshikawa TF,Aoki T,Ohira T,Matsumoto I,Ueno K,Miyazaki T,Matsuguma H,Yokouchi H,Otani T,Ito A,Sakai K,Chiba Y,Nishio K,Yamamoto N,Okamoto I,Nakagawa K,Takeda M The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma JTO CLINICAL AND RESEARCH REPORTS 2024 Apr;5(4):(沖塩協一)
25. Kako J,Kajiwara K,Kobayashi M,Kanno Y,Morikawa M,Nakano K,Matsuda Y,Shimizu Y,Niino M,Suzuki M,Shimazu T Applicability of Nursing Support for Patients With Terminal Cancer and Their Families: A Delphi Study AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE 2024 Apr 5;42(2):145-154.(松田能宣)
26. Hasegawa T,Mori M,Yamaguchi T,Imai K,Matsuda Y,Maeda I,Hatano Y,Yokomichi N,Hamano J,Morita T Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study Journal of Palliative Medicine 2024 Dec 5;(松田能宣)
27. Shimaya M,Inagaki Y,Arai T,Kawakami M,Takeuchi N,Sumikawa H,Shimizu S,Takimoto T,Inoue Y Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome Internal medicine 2024 May;63(10):1451-1457.(島矢未奈子)
28. Taniguchi Y,Arai T,Tsuji T,Sugimoto C,Tachibana K,Akira M,Inoue Y Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases Journal of Thoracic Disease 2024 May;16(5):3129-+.(谷口善彦)
29. Hoshida Y,Tsujii A,Ohshima S,Saeki Y,Yagita M,Miyamura T,Katayama M,Kawasaki T,Hiramatsu Y,Oshima H,Murayama T,Higa S,Kuraoka K,Hirano F,Ichikawa K,Kurosawa M,Suzuki H,Chiba N,Sugiyama T,Minami Y,Niino H,Ihata A,Saito I,Mitsuo A,Maejima T,Kawashima A,Tsutani H,Takahi K,Kasai T,Shinno Y,Tachiyama Y,Teramoto N,Taguchi K,Naito S,Yoshizawa S,Ito M,Suenaga Y,Mori S,Nagakura S,Yoshikawa N,Nomoto M,Ueda A,Nagaoka S,Tsuura Y,Setoguchi K,Sugii S,Abe A,Sugaya T,Sugahara H,Fujita S,Kunugiza Y,Iizuka N,Yoshihara R,Yabe H,Fujisaki T,Morii E,Takeshita M,Sato M,Saito K,Matsui K,Tomita Y,Furukawa H,Tohma S Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders Arthritis & rheumatology 2024 Jun 10;76(6):869-881.(笠井孝彦)
30. Kurahara Y,Shimatani Y Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection JMA Journal 2024 Jul 16;7(3):441-442.(倉原優)
31. Amano K,Okamura S,Matsuda Y,Baracos VE,Mori N,Miura T,Tatara R,Kessoku T,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with depression in patients with advanced cancer Supportive Care in Cancer 2024 Jul;32(7):(松田能宣)
32. Sakurai T,Kanou T,Funaki S,Fukui E,Kimura T,Ose N,Inoue Y,Shintani Y Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study Respiratory investigation 2024 Jul;62(4):657-662.(井上義一)
33. Inoue Y,Kitamura H,Okamoto M,Ogura T,Nishioka Y,Kuwana M,Taniguchi A,Ito T,Rohr KB,Suda T The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial Respiratory investigation 2024 Jul;62(4):589-596.(井上義一)
34. Tsuboi M,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Tokito T,Mio T,Adachi H,Kozuki T,Sone T,Seike M,Toyooka S,Kitagawa H,Koto R,Yamazaki S,Horinouchi H Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study Thoracic cancer 2024 Jul;15(20):1541-1552.(安宅信二)
35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Inagaki Y,Nosaki K,Fukumitsu K,Akechi T Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer Supportive Care in Cancer 2024 Jul;32(7):(稲垣雄士)
36. Miwa S,Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigators Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study Palliative Medicine Reports 2024 Jul 1;5(1):225-233.(松田能宣)
37. Kojima K,Samejima H,Iguchi T,Tokunaga T,Okishio K,Yoon H Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer Scientific reports 2024 Jul 4;14(1):(小島健介)
38. Enomoto T,Shirai Y,Takeda Y,Edahiro R,Shichino S,Nakayama M,Takahashi-Itoh M,Noda Y,Adachi Y,Kawasaki T,Koba T,Futami Y,Yaga M,Hosono Y,Yoshimura H,Amiya S,Hara R,Yamamoto M,Nakatsubo D,Suga Y,Naito M,Masuhiro K,Hirata H,Iwahori K,Nagatomo I,Miyake K,Koyama S,Fukushima K,Shiroyama T,Naito Y,Futami S,Natsume-Kitatani Y,Nojima S,Yanagawa M,Shintani Y,Nogami-Itoh M,Mizuguchi K,Adachi J,Tomonaga T,Inoue Y,Kumanogoh A SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis Takatoshi Enomoto, ... , Yoshikazu Inoue, Atsushi Kumanogoh JCI Insight 2024 Jul 10;9(11):(井上義一)
39. Nakano K,Kanno Y,Kajiwara K,Kobayashi M,Morikawa M,Matsuda Y,Shimizu Y,Shimazu T,Kako J Nursing Support for Constipation in Patients with Cancer: A Scoping Review Journal of Palliative Medicine 2024 Jul 29;28(1):115-122.(松田能宣)
40. Kurahara Y,Tanaka Y,Kobayashi T,Yoshida S,Tsuyuguchi K Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease Journal of Infection and Chemotherapy 2024 Aug;30(8):780-784.(倉原優)
41. Hamamoto Y,Kawamura M,Uchida H,Hiramatsu K,Katori C,Asai H,Shimizu S,Egawa S,Yoshida K The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model International Journal of Surgical Pathology 2024 Aug;32(5):890-894.(清水重喜)
42. Shimizu M,Maeda I,Kessoku T,Ishiki H,Matsuura T,Hiratsuka Y,Matsuda Y,Hasegawa T,Imai K,Oyamada S,Satomi E The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study Supportive Care in Cancer 2024 Aug;32(8):(松田能宣)
43. Yaga M,Hasegawa K,Ikeda S,Matsubara M,Hiroshima T,Kimura T,Shirai Y,Tansri W,Uehara H,Tachikawa M,Okairi Y,Sone M,Mori H,Kogue Y,Akamine H,Okuzaki D,Kawagishi K,Kawanaka S,Yamato H,Takeuchi Y,Okura E,Kanzaki R,Okami J,Nakamichi I,Nakane S,Kobayashi A,Iwazawa T,Tokunaga T,Yokouchi H,Yano Y,Uchida J,Mori M,Komuta K,Tachi T,Kuroda H,Kijima N,Kishima H,Ichii M,Futami S,Naito Y,Shiroyama T,Miyake K,Koyama S,Hirata H,Takeda Y,Funaki S,Shintani Y,Kumanogoh A,Hosen N CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy Scientific reports 2024 Aug 2;14(1):(德永俊照)
44. Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status BMC Pulmonary Medicine 2024 Aug 24;24(24):407.(谷口善彦)
45. Takimoto T, Sumikawa H, Inoue Y, Arai T. Auto-Fluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Auto-Fluorescence Sign. American Journal of Respiratory and Critical Care Medicine 2024 Sep;210(5):665-668.(滝本宜之)
46. Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy Thoracic Cancer 2024 Sep;15(26):1882-1888.(露口一成)
47. Tanaka Y,Kobayashi T,Shimizu S,Kurahara Y Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug Internal medicine 2024 Sep;63(18):2587-2588.(田中悠也)
48. Ueno M,Egashira R,Hashisako M,Fujimoto K,Fukuda T,Hayashida Y,Sumikawa H,Tominaga J,Tanaka T,Terasaki Y,Fukuoka J,Nishioka Y,Aoki T,Gabata T,Hatabu H,Johkoh T Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence Japanese Journal of Radiology 2024 Sep;42(9):993-1002.(澄川裕充)
49. Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer 2024 Sep;195107917.(田宮朗裕)
50. Moda M,Sumikawa H,Shintani R,Takeuchi N,Kagawa T,Takimoto T,Arai T Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease Respiratory investigation 2024 Sep;62(5):872-878.(茂田光弘)
51. Matsumoto K,Yamamoto Y,Shiroyama T,Kuge T,Mori M,Tamiya M,Kinehara Y,Tamiya A,Suzuki H,Tobita S,Ueno K,Niki T,Nagatomo I,Takeda Y,Kumanogoh A Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study Targeted Oncology 2024 Sep;19(5):757-767.(田宮朗裕)
52. Takimoto T,Sumikawa H,Inoue Y,Arai T Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome Negative Autofluorescence Sign American Journal of Respiratory and Critical Care Medicine 2024 Sep 1;210(5):665-668.(滝本宜之)
53. Enomoto N,Nakai S,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Fujii M,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Nakamura Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study Respiratory Research 2024 Sep 28;25(1):(澄川裕充)
54. Kojima K,Samejima H,Okishio K,Tokunaga T,Yoon H,Atagi S Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study BMJ Open Respiratory Research 2024 Sep 28;11(1):(小島健介)
55. Kubo K,Sakuraya M,Sugimoto H,Takahashi N,Kano K,Yoshimura J,Egi M,Kondo Y Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis Critical Care Medicine 2024 Oct;52(10):e522-e534.(杉本裕史)
56. Shibaki R,Fujimoto D,Miyauchi E,Tsukita Y,Nakachi I,Arai D,Sakata Y,Shingu N,Shimokawa T,Kijima T,Tamiya M,Kawana S,Harai S,Saito G,Sato Y,Yokoyama T,Sakata S,Taniguchi Y,Hata A,Matsumoto H,Yamaguchi T,Yamamoto N Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial Lung Cancer 2024 Oct;196(谷口善彦)
57. Tsukaguchi A,Tamiya A,Fukuda S,Iwahashi Y,Kanaoka K,Tanaka Y,Inagaki Y,Taniguchi Y,Nakao K,Kagawa T,Matsuda Y,Okishio K Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer Anticancer Research 2024 Oct;44(10):4517-4524.(塚口晃洋)
58. Sumikawa H,Johkoh T,Egashira R,Sugiura H,Sugimoto C,Tanaka T,Nakamura M,Kuriu A,Tomiyama N,Fujisawa T,Nakamura Y,Suda T Variability of radiological and clinical features in cases with usual interstitial pneumonia without honeycombing European Journal of Radiology 2024 Oct;179(澄川裕充)
59. Wijsenbeek MS,Swigris JJ,Spagnolo P,Kolb M,Kreuter M,Nunes H,Stansen W,Rohr KB,Inoue Y,INBUILD Trial Investigators Worsening dyspnoea as a predictor of progression of pulmonary fibrosis European Respiratory Journal 2024 Oct;64(4):(井上義一)
60. Kako J,Morikawa M,Kajiwara K,Kobayashi M,Kanno Y,Nakano K,Matsuda Y Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan Palliative Medicine Reports 2024 Oct 1;5(1):440-444.(松田能宣)
61. Yamaguchi T,Matsuda Y,Watanabe H,Kako J,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,JSPM Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine Journal of Palliative Medicine 2024 Oct 1;27(10):1404-1414.(松田能宣)
62. Kajiwara K,Kobayashi M,Nakano K,Kanno Y,Morikawa M,Matsuda Y,Kako J Use of Nursing Support Among Nurses for Caregiver Burden in Family Caregivers of Terminally Ill Patients with Cancer in Palliative Care Units in Japan: Multisite Cross-Sectional Study Palliative Medicine Reports 2024 Oct 1;5(1):425-429.(松田能宣)
63. Sakura K,Kuroyama M,Shintani Y,Funaki S,Atagi S,Kadota Y,Kuribayashi K,Kijima T,Nakano T,Nakajima T,Sasai M,Okumura M,Kaneda Y Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial Cancer Immunology Immunotherapy 2024 Oct 3;73(12):(安宅信二)
64. Hasuo H,Ishiki H,Matsuda Y,Matsuoka H,Kosugi K,Xing M,Akiyama Y,Matsumoto Y,Ishikawa H Trigger point injections for myofascial pain in terminal cancer: a randomized trial Pain Medicine 2024 Oct 12;26(1):14-21.(松田能宣)
65. Kondoh Y,Furukawa T,Hozumi H,Suda T,Egashira R,Jokoh T,Fukuoka J,Kuwana M,Teramachi R,Fujisawa T,Hasegawa Y,Ogura T,Miyazaki Y,Oyama S,Teramukai S,Horiguchi G,Naito A,Inoue Y,Ichikado K,Bando M,Tomioka H,Nishioka Y,Chiba H,Ebina M,Nakanishi Y,Satoh K,Shiratori Y,Hashimoto N,Ishii M The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis BMC pulmonary medicine 2024 Oct 14;24(1):(井上義一)
66. Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU; representatives of the sarcoidosis community: Nicole Goh, Anne Holland, Johann Hochreiter, Selene Kock, Karolien Verheyen, Johan Verbraecken, André Cantin, Ashley Gillson, Nathan Hambly, Martin Kolb, Elisabeth Bendstrup, Anna Leistiko, Janne Møller, Riitta Kaarteenaho, Bruno Crestani, Dominique Israël-Biet, Fleur Cohen Aubart, Hilario Nunes, Dominique Valeyre, Francesco Bonella, Katharina Buschulte, Ulrich Costabel, Peter Kortsen, Michael Kreuter, Peter Luedike, Bernd Quadder, Renate Braune, Dirk Skowasch, Katerina Antoniou, Demosthenes Bouros, Athena Gogali, George A Margaritopoulos, Despoina Papakosta, Spyros A Papiris, Effrosyni D Manali, Argyris Tzouvelekis, Vasilios Tzilas, Aditya Agrawal, Surender Kashyap, Vijay Narain Tyagi, Desai Unnati, Atefeh Abedini, Sean Phelan, Elena Bargagli, Francesco Cinetto, Marco Confalonieri, Paola Confalonieri, Sergio Harari, Fabrizio Luppi, Filippo Martone, Anna Palmieri, Paola Rottoli, Francesco Salton, Ricardo Scarpa, Claudio Tana, Sara Tomassetti, Arata Azuma, Naoki Inui, Yutaro Nakamura, Yoshikazu Inoue, Yoshinori Tanino, Noorul Afidza Muhammad, Frouke van Beek, Lenze den Boer, Karin Boomars, Paul Bresser, Laura Claessen, Marjon Elfferich, Roel Erckens, Sanne van Helmondt, Bekir Karakaya, Jan C Grutters, Elske Hoitsma, Károly Illy, Tim L Jansen, Vivienne Kahlmann, Chris Knoet, Ingrid Korenromp, Ton Lenssen, Karen Maassen Vd Brinkdrs, Johannes Jurgen Mager, Rik Marcellis, Jelle Miedema, Trudeke Möller, Linda A A Moonen, Karen Moor, Rémy L M Mostard, Willemien Nienhuis, Esther Nossent, Michelle Paulus, Rudolf Ponds, George Nossent, Marian Quanjel, Felix Rottenberg, Jonathan S O van de Sande, Ruud Segers, Shalini D Soechitram, AnneLoes van Staa, Bert Strookappe, Martin Swaans, Leon van den Toorn, Marjo J T van de Ven, Mareye Voortman, Adriane Dore Marie Vorselaars, Lenneke Vente, Petal A Wijnen, Marlies Wijsenbeek, Jolanda De Vries, Arthur van Zanten, Michael Durheim, Øystein Rasch-Halvorsen, Anders Tøndell, Anna Dubaniewicz, Wojciech Piotrowski, Bartlomiej Roter, Carlos Robalo Cordeiro, Tiago Alfaro, Irina Strambu, Alexander Vizel, Rafael Cano, Eva Balcells, Diego Castillo, Joel Francesqui, Juan Mañá, Maria Molina, Inigo Ojanguren, Jose Antonio Rodriguez Portal, Jacobo Sellares, Elizabeth Arkema, Pernilla Darlington, Per Eldhagen, Katinka Elfström, Johan Grunewald, Susanna Kullberg, Natalia V Rivera, Marios Rossides, Joanna Werner, Irem Dincer, Gülcan Koç, Canan Yucesan, Ozlem Ozdemir Kumbasar, Surinder Birring, Jeanette Boyd, Leo Casimo, Christopher Huntley, Vasileios Kouranos, Jaqui Newton, Lisa Spencer, Mark Spears, Paula Barreras, Yvette Cozier, Elliott Crouser, Logan Harper, W Ennis James, Lisa Maier, Shu-Yi Liao, Adam Morgenthau, Ogugua Ndili Obi, Divya Patel, Frank Rivera, Milton D Rossman, Michelle Sharp, Maggie Sharma, Jonas C Schupp, Barney J Stern, Nadera Sweiss, Jinny Tavee, Daniel Zank, Galyna Gumeniuk, Volodymyr Gavrysyuk, Levgeniia Merenkova. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis Lancet Respiratory Medicine 2024 Nov;12(11):848-851.(井上義一)
67. Kako J,Kobayashi M,Matsuda Y,Inoue S,Tanimukai H,Wada S,Hasegawa T Nonpharmacological Intervention for Delirium in Patients With Cancer: A Scoping Review Journal of Pain and Symptom Management 2024 Nov;68(5):(松田能宣)
68. Kanaoka K,Arai T,Takimoto T,Moda M,Shintani R,Ryuge M,Takeuchi N,Kagawa T,Tachibana K,Inoue Y,Sumikawa H,Takeda M,Shimizu S Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study Respiratory investigation 2024 Nov;62(6):1161-1167.(金岡賢輔)
69. Kawachi H,Tamiya M,Oya Y,Saito G,Taniguchi Y,Matsumoto H,Sato Y,Otsuki T,Suzuki H,Fukuda Y,Tanaka S,Tsukita Y,Uchida J,Sakata Y,Nakatani Y,Shibaki R,Arai D,Okada A,Hara S,Takayama K,Nishino K Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005) Clinical Lung Cancer 2024 Nov;25(7):643-652.(谷口善彦)
70. Yoshida S,Tsuyuguchi K,Kobayashi T,Kurahara Y,Shimatani Y,Arai T Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease Respiratory Investigation 2024 Nov;62(6):1142-1148.(𠮷田志緒美)
71. Shimoda M,Tanaka Y,Ohe T,Ishiguro T,Suzuki A,Kurahara Y,Shimatani Y,Matsushima H,Kusano K,Ohta H,Yanagisawa S,Kozu Y,Yui T,Igarashi S,Kimizuka Y,Honda K,Otani S,Chiba S,Xu DJ,Mitsui M,Waseda Y,Ishii H Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase Respiratory Investigation 2024 Nov;62(6):963-969.(倉原優)
72. Amano K,Koshimoto S,Okamura S,Sakaguchi T,Arakawa S,Matsuda Y,Tokoro A,Takeuchi T,Satomi E,Wada T,Wada M,Yamada T,Mori N Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer Healthcare 2024 Dec;12(24):(松田能宣)
73. Nii T, Fujiwara K, Kobayashi T, Hagiwara E, Fukushima K, Morimoto K, Tsuyuguchi K, Ogura T, Kida H. Serodiagnosis of M. abscessus species pulmonary disease using anti-glycopeptidolipid-core IgA antibody. IJTLD OPEN 2024 Dec;1(12):575－577.(露口一成)
74. Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease Journal of Infection and Chemotherapy 2025 Jan;31(1):102441.(倉原優)
75. Sugisaka J,Fujimoto D,Tamiya M,Hata A,Matsumoto H,Yokoyama T,Taniguchi Y,Uchida J,Sato Y,Kijima T,Tanaka H,Furuya N,Masuda T,Sakata Y,Miyauchi E,Saito G,Miura S,Yamaguchi T,Daga H,Sakata S,Yamamoto N,Akamatsu H Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study Lung Cancer 2025 Jan;199(谷口善彦)
76. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clinical Lung Cancer 2025 Jan;26(1):1-8.(田宮朗裕)
77. Horinouchi H,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Kozuki T,Tokito T,Oizumi S,Seike M,Ohashi K,Mio T,Sone T,Iwao C,Iwane T,Koto R,Tsuboi M Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study Lung Cancer 2025 Jan;199(安宅信二)
78. Arai T,Inoue Y,Akasaka K,Masunaga A,Fujita M,Yamaguchi E,Saigusa M,Murakami K,Kurahara Y,Tsuyuguchi K,Suzuki T,Miyazaki Y,Bando M,Suda T Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 2025 Jan;63(1):20-26.(新井徹)
79. Akapelwa M, Kapalamula T, Moonga L, Bwalya P, Solo E, Chizimu J, Thapa J, Hayashida K, Hang’ombe B, Munyeme M, Tamaru A, Wada W, Yoshida S, Kodera T, Kawase M, Gordon S, Yamada K, Nakajima C, Suzuki Y Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) method for differential detection of Mycobacterium bovis and Mycobacterium tuberculosis by dipstick DNA chromatography Microbiology Spectrum 2025 Jan 3;(𠮷田志緒美)
80. Inoue Y,Ogura T,Azuma A,Kondoh Y,Homma S,Muraishi K,Ikeda R,Ochiai K,Sugiyama Y,Nukiwa T Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy 2025 Feb;42(2):1075-1093.(井上義一)
81. Takashi Nishihara, Hideo Ishikawa, Kazunari Tsuyuguchi, Shoichi Fukuda, Hiromitsu Sumikawa Reevaluating the Role of Bronchoscopy Prior to Bronchial Artery Embolization in Non-Intubated Patients with Hemoptysis due to Bronchiectasis and Chronic Pulmonary Infection Chest Pulmonary 2025 Mar;online first(西原昂)
82. Takimoto T,Takeuchi N,Inoue Y,Arai T Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis PULMONOLOGY 2024 Sep 30;30(5):488-491.(滝本宜之)
83. Ozawa Y,Koh Y,Hase T,Chibana K,Kaira K,Okishio K,Ichihara E,Murakami S,Shimokawa M,Yamamoto N Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Therapeutic Advances in Medical Oncology 2024;16(沖塩協一)
84. Kurahara Y,Shimatani Y,Ryuge M,Tsuyuguchi K Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae Internal medicine 2024;63(6):879-880.(倉原優)
85. Kurahara Y Tuberculous Bronchostenosis Manifesting as the "CT Angiogram Sign" Internal medicine 2024;63(18):2581-2582.(倉原優)
和文原著・著書等
1. 田中 悠也, 倉原 優．病気のはなし 結核検査と技術2024;52(2): 124-128.
2. 松田 能宣．不安と呼吸困難呼吸器内科2024;45(4):422～426.
3. 倉原 優．論文視点 コロナ肺炎の後遺症3年後も3分の1に病変残存Medical Tribune2024;57(8):3.
4. 田中 悠也, 倉原 優, 嶋谷 泰明, 小林 岳彦, 吉田 志緒美, 松本 錦之介, 露口 一成．肺非結核性抗酸菌症から菌交代し肺結核を発症した症例の検討結核2024;99(3):154.
5. 倉原 優．膿性痰で分類されていたCOPD増悪の基準に下剋上J-IDEO2024;8(3):504-505.
6. 倉原 優．ポケット呼吸器診療2024シーニュ2024;
7. 露口一成．非結核性抗酸菌症の微生物学的検査の実際呼吸器内科2024;45(6):566-570.
8. 松田能宣．パニック発作
今夜からもう困らない！夜の症状緩和 南江堂2024;128～135.
9. 松田能宣．第Ⅳ章特定集団への緩和ケア 6慢性呼吸器疾患専門家をめざす人のための緩和医療学 南江堂2024;333～336.
10. 松田能宣．非がん慢性呼吸器疾患：エビデンスアップデート医学のあゆみ2024;289(10):771～775.
11. 倉原 優．エアロゾルと抗酸菌感染症呼吸器内科2024;45(6):623-628.
12. 倉原 優．なぜ右の横隔膜が弱いのか？J-IDEO2024;8(4):684-685.
13. 新井 徹．肺胞蛋白症呼吸器内科診療の掟2024;502～510.
14. 田中 悠也, 倉原 優パルスオキシメータ呼吸器ジャーナル2024;72376-378.
15. 田中 悠也, 倉原 優高高度における呼吸生理呼吸器ジャーナル2024;72392-394.
16. 田中 悠也, 倉原 優「Happy hypoxia」について再考する呼吸器ジャーナル2024;72491-493.
17. 倉原 優、森本耕三「世界気管支拡張症デー」広く病気の認知をJ-BREATH2024;(133):11.
18. 倉原 優．肺NTM症とエストロゲン枯渇J-IDEO2024;8(5):834-836.
19. 和田佐保、松田能宣、井上真一郎、角甲純、谷向仁【ガイドラインを実践できる,エビデンスと臨床のギャップが埋まる 向精神薬のエビデンスベースドプラクティス】(第2章)いまはこうする!ガイドラインのトリセツ せん妄(解説)薬事2024;66(14):2623-2629.
20. 松田能宣．【精神科医として関わるがん治療関連精神症状】進行がんにおける低活動型せん妄の診断と対応(解説)臨床精神薬理2024;27(10):1013-1021.
21. 𠮷田志緒美, 山本剛, 石井良和, 御手洗聡抗酸菌検査のアンケート調査2022における結果報告 結核2024;99(6):163-172.
22. 田中 悠也, 倉原 優喘息・COPD鑑別が難しい症例の問診・身体所見の実臨床でのコツ（検査に重きを置いて）. jmedmook94 今日の診療に活かせる喘息・COPD ポイント解説.今日の診療に活かせる 喘息・COPDポイント解説2024;
23. 倉原 優．慢性肺アスペルギルス症とイサブコナゾールJ-IDEO2024;8(6):982-984.
24. 露口一成．肺結核症最新ガイドラインに基づく呼吸器疾患診療指針2024;
25. 井上義一．リンパ脈管筋腫症最新ガイドラインに基づく呼吸器疾患診療指針 第６版2024;
26. 新井 徹．間質性肺炎の診断と地域連携Medical Practice2025;42(1):50～54.
27. 倉原 優．見逃したくない縦隔炎J-IDEO2025;9(1):62-64.
28. 𠮷田志緒美．検査材料抗酸菌検査ガイド20252025;31-36.
29. 井上義一．肺胞蛋白症呼吸器疾患最新の治療2025-20262025;
30. 蓮尾英明、松岡弘道、松田能宣緩和ケアにおける悩ましい感情のひも解き方Difficult Patient2025;
31. 倉原 優．「肺NTM症の診断基準」の改訂J-IDEO2025;9(2):282-283.
32. 𠮷田志緒美．病理組織標本で抗酸菌が観察されていますが，培養で発育しないと言われました．どのような抗酸菌を想定し，追加対応はどのようにすればよいでしょうか？臨床検査2025増大号 「さっと読めてぱっとわかる！感染症診断メモ」2025;69(4):2024年度
英文論文
1. A Yanagisawa, T Takimoto, Y Kurahara, K Tsuyuguchi, S Yoshida, M Hirose, Y Inoue, T Arai A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy Internal Medicine 2023 Nov;63(14):2043-2047.(柳澤篤)
2. Okuma Y,Kubota K,Shimokawa M,Hashimoto K,Kawashima Y,Sakamoto T,Wakui H,Murakami S,Okishio K,Hayashihara K,Ohe Y First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial JAMA Oncology 2024 Jan;10(1):43-51.(沖塩協一)
3. Tomioka H,Miyazaki Y,Inoue Y,Egashira R,Kawamura T,Sano H,Johkoh T,Takemura T,Hisada T,Fukuoka J,Comm Japanese Resp Soc Japane Japanese clinical practice guide 2022 for hypersensitivity pneumonitis Respiratory investigation 2024 Jan;62(1):16-43.(井上義一)
4. Tamiya A Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors Respiratory investigation 2024 Jan;62(1):85-89.(田宮朗裕)
5. Nishio M,Murakami S,Kawakami H,Okishio K,Tamiya M,Kobayashi H,Fujimoto D,Sugawara S,Kozuki T,Oya Y,Izumi H,Shiroyama T,Satouchi M,Yamamoto N,Kaname S,Matsuoka D,Otake Y,Takase T,Semba T,Azuma K Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort Cancer Research Communications 2024 Jan;4(1):226-235.(沖塩協一)
6. Matsumoto K,Shiroyama T,Tamiya M,Minami T,Kinehara Y,Tamiya A,Suga Y,Kuge T,Mori M,Suzuki H,Tobita S,Ueno K,Namba Y,Tetsumoto S,Niki T,Morimura O,Osa A,Nishino K,Nagatomo I,Takeda Y,Kijima T,Kumanogoh A Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study Cancer Immunology Immunotherapy 2024 Jan;73(1):(田宮朗裕)
7. Kobayashi T,Tsuyuguchi K,Shimatani Y,Matsuda Y,Kagawa T,Takimoto T,Takeuchi N,Arai T,Inoue Y Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis Journal of Infection and Chemotherapy 2024 Jan;30(1):7-11.(小林岳彦)
8. Walsh SLF, De Backer J, Prosch H, Langs G, Calandriello L, Cottin V, Brown KK, Inoue Y, Tzilas V, Estes E; Open Source Imaging Consortium (OSIC). Towards the adoption of quantitative computed tomography in the management of interstitial lung disease European Respiratory Review 2024 Jan 31;33(171):230055.(井上義一)
9. Shibaki R,Fujimoto D,Nozawa T,Sano A,Kitamura Y,Fukuoka J,Sato Y,Kijima T,Matsumoto H,Yokoyama T,Miura S,Hata A,Tamiya M,Taniguchi Y,Sugisaka J,Furuya N,Tanaka H,Yamamoto N,Koh Y,Akamatsu H Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2024 Feb;12(2):(谷口善彦)
10. Mitsudomi T,Ito H,Okada M,Sugawara S,Shio Y,Tomii K,Okami J,Sakakura N,Kubota K,Takamochi K,Atagi S,Tsuboi M,Oizumi S,Ikeda N,Ohde Y,Ntambwe I,Mahmood J,Cai JL,Tanaka F Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816 Cancer Science 2024 Feb;115(2):540-554.(安宅信二)
11. Ikeda S,Tsuboi M,Sakai K,Misumi T,Akamatsu H,Shoda H,Sakakura N,Nakamura A,Ohde Y,Hayashi H,Okishio K,Okada M,Yoshino I,Okami J,Takahashi K,Ikeda N,Tanahashi M,Tambo Y,Saito H,Toyooka S,Inokawa H,Chen-Yoshikawa T,Yokoyama T,Okamoto T,Yanagitani N,Oki M,Takahama M,Sawa K,Tada H,Nakagawa K,Mitsudomi T,Nishio K NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study Molecular Oncology 2024 Feb;18(2):305-316.(沖塩協一)
12. Kagawa T,Kurahashi K,Seki T,Kawasaki Y,Nahara I,Takeda C,Yonekura H,Tanaka S,Kawakami K The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database Journal of Anesthesia 2024 Feb;38(1):92-97.(香川智子)
13. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Taniguchi Y,Nosaki K,Fukumitsu K,Akechi T Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer Oncologist 2024 Feb 2;29(2):e282-e289.(松田能宣)
14. Akira M,Suganuma N Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia Canadian Respiratory Journal 2024 Feb 14;2024(審良正則)
15. Kurahara Y,Okamori H,Tsuyuguchi K A Large Cavity Associated with Pulmonary Infarction Internal medicine 2024 Mar;63(20):2867-2868.(倉原優)
16. Morimoto K,Nonaka M,Yamazaki Y,Nakagawa T,Takasaki J,Tsuyuguchi K,Kitada S,Jumadilova Z,Yuen DW,Ciesielska M,Hasegawa N Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study Respiratory investigation 2024 Mar;62(2):284-290.(露口一成)
17. Molina TJ,Roden AC,Szolkowska M,Shimizu S,Moreira AL,Chalabreysse L,Besse B,de Montpr V,Marom EM,Detterback F,Girard N,Nicholson AG,Marx A International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study Lung Cancer 2024 Mar;189(清水重喜)
18. Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry. JACC-ASIA 2024 Mar;4(5):403-417.(井上義一)
19. Isobe K,Nakamura Y,Sakamoto S,Tomii K,Takimoto T,Miyazaki Y,Matsumoto M,Sugino K,Ichikado K,Moriguchi S,Yamaguchi K,Baba T,Ozasa H,Igata F,Anabuki K,Homma S,Date H,Suda T,Kishi K Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia ERJ Open Research 2024 Mar 1;10(2):(滝本宜之)
20. Richeldi L,Schiffman C,Behr J,Inoue Y,Corte TJ,Cottin V,Jenkins RG,Nathan SD,Raghu G,Walsh SLF,Jayia PK,Kamath N,Martinez FJ Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial American Journal of Respiratory and Critical Care Medicine 2024 May 1;209(9):1132-1140.(井上義一)
21. Wada T,Yoshida S,Yamamoto T,Nonaka L,Fukushima Y,Nakajima C,Suzuki Y,Imajoh M Application of Genomic Epidemiology of Pathogens to Farmed Yellowtail Fish Mycobacteriosis in Kyushu, Japan Microbes and Environments 2024;39(2):ME24011.(𠮷田志緒美)
22. Amano K,Baracos VE,Mori N,Okamura S,Yamada T,Miura T,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer Clinical Nutrition ESPEN 2024 Apr;60313-319.(松田能宣)
23. Enomoto N,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Aono Y,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Sano T,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Nakamura Y,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study Respiratory Medicine 2024 Apr;224(澄川裕充)
24. Kanemura H,Yokoyama T,Nakajima R,Nakamura A,Kuroda H,Kitamura Y,Shoda H,Mamesaya N,Miyata Y,Okamoto T,Okishio K,Oki M,Sakairi Y,Chen-Yoshikawa TF,Aoki T,Ohira T,Matsumoto I,Ueno K,Miyazaki T,Matsuguma H,Yokouchi H,Otani T,Ito A,Sakai K,Chiba Y,Nishio K,Yamamoto N,Okamoto I,Nakagawa K,Takeda M The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma JTO CLINICAL AND RESEARCH REPORTS 2024 Apr;5(4):(沖塩協一)
25. Kako J,Kajiwara K,Kobayashi M,Kanno Y,Morikawa M,Nakano K,Matsuda Y,Shimizu Y,Niino M,Suzuki M,Shimazu T Applicability of Nursing Support for Patients With Terminal Cancer and Their Families: A Delphi Study AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE 2024 Apr 5;42(2):145-154.(松田能宣)
26. Hasegawa T,Mori M,Yamaguchi T,Imai K,Matsuda Y,Maeda I,Hatano Y,Yokomichi N,Hamano J,Morita T Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study Journal of Palliative Medicine 2024 Dec 5;(松田能宣)
27. Shimaya M,Inagaki Y,Arai T,Kawakami M,Takeuchi N,Sumikawa H,Shimizu S,Takimoto T,Inoue Y Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome Internal medicine 2024 May;63(10):1451-1457.(島矢未奈子)
28. Taniguchi Y,Arai T,Tsuji T,Sugimoto C,Tachibana K,Akira M,Inoue Y Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases Journal of Thoracic Disease 2024 May;16(5):3129-+.(谷口善彦)
29. Hoshida Y,Tsujii A,Ohshima S,Saeki Y,Yagita M,Miyamura T,Katayama M,Kawasaki T,Hiramatsu Y,Oshima H,Murayama T,Higa S,Kuraoka K,Hirano F,Ichikawa K,Kurosawa M,Suzuki H,Chiba N,Sugiyama T,Minami Y,Niino H,Ihata A,Saito I,Mitsuo A,Maejima T,Kawashima A,Tsutani H,Takahi K,Kasai T,Shinno Y,Tachiyama Y,Teramoto N,Taguchi K,Naito S,Yoshizawa S,Ito M,Suenaga Y,Mori S,Nagakura S,Yoshikawa N,Nomoto M,Ueda A,Nagaoka S,Tsuura Y,Setoguchi K,Sugii S,Abe A,Sugaya T,Sugahara H,Fujita S,Kunugiza Y,Iizuka N,Yoshihara R,Yabe H,Fujisaki T,Morii E,Takeshita M,Sato M,Saito K,Matsui K,Tomita Y,Furukawa H,Tohma S Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders Arthritis & rheumatology 2024 Jun 10;76(6):869-881.(笠井孝彦)
30. Kurahara Y,Shimatani Y Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection JMA Journal 2024 Jul 16;7(3):441-442.(倉原優)
31. Amano K,Okamura S,Matsuda Y,Baracos VE,Mori N,Miura T,Tatara R,Kessoku T,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with depression in patients with advanced cancer Supportive Care in Cancer 2024 Jul;32(7):(松田能宣)
32. Sakurai T,Kanou T,Funaki S,Fukui E,Kimura T,Ose N,Inoue Y,Shintani Y Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study Respiratory investigation 2024 Jul;62(4):657-662.(井上義一)
33. Inoue Y,Kitamura H,Okamoto M,Ogura T,Nishioka Y,Kuwana M,Taniguchi A,Ito T,Rohr KB,Suda T The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial Respiratory investigation 2024 Jul;62(4):589-596.(井上義一)
34. Tsuboi M,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Tokito T,Mio T,Adachi H,Kozuki T,Sone T,Seike M,Toyooka S,Kitagawa H,Koto R,Yamazaki S,Horinouchi H Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study Thoracic cancer 2024 Jul;15(20):1541-1552.(安宅信二)
35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Inagaki Y,Nosaki K,Fukumitsu K,Akechi T Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer Supportive Care in Cancer 2024 Jul;32(7):(稲垣雄士)
36. Miwa S,Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigators Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study Palliative Medicine Reports 2024 Jul 1;5(1):225-233.(松田能宣)
37. Kojima K,Samejima H,Iguchi T,Tokunaga T,Okishio K,Yoon H Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer Scientific reports 2024 Jul 4;14(1):(小島健介)
38. Enomoto T,Shirai Y,Takeda Y,Edahiro R,Shichino S,Nakayama M,Takahashi-Itoh M,Noda Y,Adachi Y,Kawasaki T,Koba T,Futami Y,Yaga M,Hosono Y,Yoshimura H,Amiya S,Hara R,Yamamoto M,Nakatsubo D,Suga Y,Naito M,Masuhiro K,Hirata H,Iwahori K,Nagatomo I,Miyake K,Koyama S,Fukushima K,Shiroyama T,Naito Y,Futami S,Natsume-Kitatani Y,Nojima S,Yanagawa M,Shintani Y,Nogami-Itoh M,Mizuguchi K,Adachi J,Tomonaga T,Inoue Y,Kumanogoh A SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis Takatoshi Enomoto, ... , Yoshikazu Inoue, Atsushi Kumanogoh JCI Insight 2024 Jul 10;9(11):(井上義一)
39. Nakano K,Kanno Y,Kajiwara K,Kobayashi M,Morikawa M,Matsuda Y,Shimizu Y,Shimazu T,Kako J Nursing Support for Constipation in Patients with Cancer: A Scoping Review Journal of Palliative Medicine 2024 Jul 29;28(1):115-122.(松田能宣)
40. Kurahara Y,Tanaka Y,Kobayashi T,Yoshida S,Tsuyuguchi K Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease Journal of Infection and Chemotherapy 2024 Aug;30(8):780-784.(倉原優)
41. Hamamoto Y,Kawamura M,Uchida H,Hiramatsu K,Katori C,Asai H,Shimizu S,Egawa S,Yoshida K The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model International Journal of Surgical Pathology 2024 Aug;32(5):890-894.(清水重喜)
42. Shimizu M,Maeda I,Kessoku T,Ishiki H,Matsuura T,Hiratsuka Y,Matsuda Y,Hasegawa T,Imai K,Oyamada S,Satomi E The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study Supportive Care in Cancer 2024 Aug;32(8):(松田能宣)
43. Yaga M,Hasegawa K,Ikeda S,Matsubara M,Hiroshima T,Kimura T,Shirai Y,Tansri W,Uehara H,Tachikawa M,Okairi Y,Sone M,Mori H,Kogue Y,Akamine H,Okuzaki D,Kawagishi K,Kawanaka S,Yamato H,Takeuchi Y,Okura E,Kanzaki R,Okami J,Nakamichi I,Nakane S,Kobayashi A,Iwazawa T,Tokunaga T,Yokouchi H,Yano Y,Uchida J,Mori M,Komuta K,Tachi T,Kuroda H,Kijima N,Kishima H,Ichii M,Futami S,Naito Y,Shiroyama T,Miyake K,Koyama S,Hirata H,Takeda Y,Funaki S,Shintani Y,Kumanogoh A,Hosen N CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy Scientific reports 2024 Aug 2;14(1):(德永俊照)
44. Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status BMC Pulmonary Medicine 2024 Aug 24;24(24):407.(谷口善彦)
45. Takimoto T, Sumikawa H, Inoue Y, Arai T. Auto-Fluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Auto-Fluorescence Sign. American Journal of Respiratory and Critical Care Medicine 2024 Sep;210(5):665-668.(滝本宜之)
46. Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy Thoracic Cancer 2024 Sep;15(26):1882-1888.(露口一成)
47. Tanaka Y,Kobayashi T,Shimizu S,Kurahara Y Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug Internal medicine 2024 Sep;63(18):2587-2588.(田中悠也)
48. Ueno M,Egashira R,Hashisako M,Fujimoto K,Fukuda T,Hayashida Y,Sumikawa H,Tominaga J,Tanaka T,Terasaki Y,Fukuoka J,Nishioka Y,Aoki T,Gabata T,Hatabu H,Johkoh T Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence Japanese Journal of Radiology 2024 Sep;42(9):993-1002.(澄川裕充)
49. Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer 2024 Sep;195107917.(田宮朗裕)
50. Moda M,Sumikawa H,Shintani R,Takeuchi N,Kagawa T,Takimoto T,Arai T Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease Respiratory investigation 2024 Sep;62(5):872-878.(茂田光弘)
51. Matsumoto K,Yamamoto Y,Shiroyama T,Kuge T,Mori M,Tamiya M,Kinehara Y,Tamiya A,Suzuki H,Tobita S,Ueno K,Niki T,Nagatomo I,Takeda Y,Kumanogoh A Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study Targeted Oncology 2024 Sep;19(5):757-767.(田宮朗裕)
52. Takimoto T,Sumikawa H,Inoue Y,Arai T Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome Negative Autofluorescence Sign American Journal of Respiratory and Critical Care Medicine 2024 Sep 1;210(5):665-668.(滝本宜之)
53. Enomoto N,Nakai S,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Fujii M,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Nakamura Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study Respiratory Research 2024 Sep 28;25(1):(澄川裕充)
54. Kojima K,Samejima H,Okishio K,Tokunaga T,Yoon H,Atagi S Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study BMJ Open Respiratory Research 2024 Sep 28;11(1):(小島健介)
55. Kubo K,Sakuraya M,Sugimoto H,Takahashi N,Kano K,Yoshimura J,Egi M,Kondo Y Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis Critical Care Medicine 2024 Oct;52(10):e522-e534.(杉本裕史)
56. Shibaki R,Fujimoto D,Miyauchi E,Tsukita Y,Nakachi I,Arai D,Sakata Y,Shingu N,Shimokawa T,Kijima T,Tamiya M,Kawana S,Harai S,Saito G,Sato Y,Yokoyama T,Sakata S,Taniguchi Y,Hata A,Matsumoto H,Yamaguchi T,Yamamoto N Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial Lung Cancer 2024 Oct;196(谷口善彦)
57. Tsukaguchi A,Tamiya A,Fukuda S,Iwahashi Y,Kanaoka K,Tanaka Y,Inagaki Y,Taniguchi Y,Nakao K,Kagawa T,Matsuda Y,Okishio K Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer Anticancer Research 2024 Oct;44(10):4517-4524.(塚口晃洋)
58. Sumikawa H,Johkoh T,Egashira R,Sugiura H,Sugimoto C,Tanaka T,Nakamura M,Kuriu A,Tomiyama N,Fujisawa T,Nakamura Y,Suda T Variability of radiological and clinical features in cases with usual interstitial pneumonia without honeycombing European Journal of Radiology 2024 Oct;179(澄川裕充)
59. Wijsenbeek MS,Swigris JJ,Spagnolo P,Kolb M,Kreuter M,Nunes H,Stansen W,Rohr KB,Inoue Y,INBUILD Trial Investigators Worsening dyspnoea as a predictor of progression of pulmonary fibrosis European Respiratory Journal 2024 Oct;64(4):(井上義一)
60. Kako J,Morikawa M,Kajiwara K,Kobayashi M,Kanno Y,Nakano K,Matsuda Y Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan Palliative Medicine Reports 2024 Oct 1;5(1):440-444.(松田能宣)
61. Yamaguchi T,Matsuda Y,Watanabe H,Kako J,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,JSPM Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine Journal of Palliative Medicine 2024 Oct 1;27(10):1404-1414.(松田能宣)
62. Kajiwara K,Kobayashi M,Nakano K,Kanno Y,Morikawa M,Matsuda Y,Kako J Use of Nursing Support Among Nurses for Caregiver Burden in Family Caregivers of Terminally Ill Patients with Cancer in Palliative Care Units in Japan: Multisite Cross-Sectional Study Palliative Medicine Reports 2024 Oct 1;5(1):425-429.(松田能宣)
63. Sakura K,Kuroyama M,Shintani Y,Funaki S,Atagi S,Kadota Y,Kuribayashi K,Kijima T,Nakano T,Nakajima T,Sasai M,Okumura M,Kaneda Y Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial Cancer Immunology Immunotherapy 2024 Oct 3;73(12):(安宅信二)
64. Hasuo H,Ishiki H,Matsuda Y,Matsuoka H,Kosugi K,Xing M,Akiyama Y,Matsumoto Y,Ishikawa H Trigger point injections for myofascial pain in terminal cancer: a randomized trial Pain Medicine 2024 Oct 12;26(1):14-21.(松田能宣)
65. Kondoh Y,Furukawa T,Hozumi H,Suda T,Egashira R,Jokoh T,Fukuoka J,Kuwana M,Teramachi R,Fujisawa T,Hasegawa Y,Ogura T,Miyazaki Y,Oyama S,Teramukai S,Horiguchi G,Naito A,Inoue Y,Ichikado K,Bando M,Tomioka H,Nishioka Y,Chiba H,Ebina M,Nakanishi Y,Satoh K,Shiratori Y,Hashimoto N,Ishii M The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis BMC pulmonary medicine 2024 Oct 14;24(1):(井上義一)
66. Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU; representatives of the sarcoidosis community: Nicole Goh, Anne Holland, Johann Hochreiter, Selene Kock, Karolien Verheyen, Johan Verbraecken, André Cantin, Ashley Gillson, Nathan Hambly, Martin Kolb, Elisabeth Bendstrup, Anna Leistiko, Janne Møller, Riitta Kaarteenaho, Bruno Crestani, Dominique Israël-Biet, Fleur Cohen Aubart, Hilario Nunes, Dominique Valeyre, Francesco Bonella, Katharina Buschulte, Ulrich Costabel, Peter Kortsen, Michael Kreuter, Peter Luedike, Bernd Quadder, Renate Braune, Dirk Skowasch, Katerina Antoniou, Demosthenes Bouros, Athena Gogali, George A Margaritopoulos, Despoina Papakosta, Spyros A Papiris, Effrosyni D Manali, Argyris Tzouvelekis, Vasilios Tzilas, Aditya Agrawal, Surender Kashyap, Vijay Narain Tyagi, Desai Unnati, Atefeh Abedini, Sean Phelan, Elena Bargagli, Francesco Cinetto, Marco Confalonieri, Paola Confalonieri, Sergio Harari, Fabrizio Luppi, Filippo Martone, Anna Palmieri, Paola Rottoli, Francesco Salton, Ricardo Scarpa, Claudio Tana, Sara Tomassetti, Arata Azuma, Naoki Inui, Yutaro Nakamura, Yoshikazu Inoue, Yoshinori Tanino, Noorul Afidza Muhammad, Frouke van Beek, Lenze den Boer, Karin Boomars, Paul Bresser, Laura Claessen, Marjon Elfferich, Roel Erckens, Sanne van Helmondt, Bekir Karakaya, Jan C Grutters, Elske Hoitsma, Károly Illy, Tim L Jansen, Vivienne Kahlmann, Chris Knoet, Ingrid Korenromp, Ton Lenssen, Karen Maassen Vd Brinkdrs, Johannes Jurgen Mager, Rik Marcellis, Jelle Miedema, Trudeke Möller, Linda A A Moonen, Karen Moor, Rémy L M Mostard, Willemien Nienhuis, Esther Nossent, Michelle Paulus, Rudolf Ponds, George Nossent, Marian Quanjel, Felix Rottenberg, Jonathan S O van de Sande, Ruud Segers, Shalini D Soechitram, AnneLoes van Staa, Bert Strookappe, Martin Swaans, Leon van den Toorn, Marjo J T van de Ven, Mareye Voortman, Adriane Dore Marie Vorselaars, Lenneke Vente, Petal A Wijnen, Marlies Wijsenbeek, Jolanda De Vries, Arthur van Zanten, Michael Durheim, Øystein Rasch-Halvorsen, Anders Tøndell, Anna Dubaniewicz, Wojciech Piotrowski, Bartlomiej Roter, Carlos Robalo Cordeiro, Tiago Alfaro, Irina Strambu, Alexander Vizel, Rafael Cano, Eva Balcells, Diego Castillo, Joel Francesqui, Juan Mañá, Maria Molina, Inigo Ojanguren, Jose Antonio Rodriguez Portal, Jacobo Sellares, Elizabeth Arkema, Pernilla Darlington, Per Eldhagen, Katinka Elfström, Johan Grunewald, Susanna Kullberg, Natalia V Rivera, Marios Rossides, Joanna Werner, Irem Dincer, Gülcan Koç, Canan Yucesan, Ozlem Ozdemir Kumbasar, Surinder Birring, Jeanette Boyd, Leo Casimo, Christopher Huntley, Vasileios Kouranos, Jaqui Newton, Lisa Spencer, Mark Spears, Paula Barreras, Yvette Cozier, Elliott Crouser, Logan Harper, W Ennis James, Lisa Maier, Shu-Yi Liao, Adam Morgenthau, Ogugua Ndili Obi, Divya Patel, Frank Rivera, Milton D Rossman, Michelle Sharp, Maggie Sharma, Jonas C Schupp, Barney J Stern, Nadera Sweiss, Jinny Tavee, Daniel Zank, Galyna Gumeniuk, Volodymyr Gavrysyuk, Levgeniia Merenkova. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis Lancet Respiratory Medicine 2024 Nov;12(11):848-851.(井上義一)
67. Kako J,Kobayashi M,Matsuda Y,Inoue S,Tanimukai H,Wada S,Hasegawa T Nonpharmacological Intervention for Delirium in Patients With Cancer: A Scoping Review Journal of Pain and Symptom Management 2024 Nov;68(5):(松田能宣)
68. Kanaoka K,Arai T,Takimoto T,Moda M,Shintani R,Ryuge M,Takeuchi N,Kagawa T,Tachibana K,Inoue Y,Sumikawa H,Takeda M,Shimizu S Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study Respiratory investigation 2024 Nov;62(6):1161-1167.(金岡賢輔)
69. Kawachi H,Tamiya M,Oya Y,Saito G,Taniguchi Y,Matsumoto H,Sato Y,Otsuki T,Suzuki H,Fukuda Y,Tanaka S,Tsukita Y,Uchida J,Sakata Y,Nakatani Y,Shibaki R,Arai D,Okada A,Hara S,Takayama K,Nishino K Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005) Clinical Lung Cancer 2024 Nov;25(7):643-652.(谷口善彦)
70. Yoshida S,Tsuyuguchi K,Kobayashi T,Kurahara Y,Shimatani Y,Arai T Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease Respiratory Investigation 2024 Nov;62(6):1142-1148.(𠮷田志緒美)
71. Shimoda M,Tanaka Y,Ohe T,Ishiguro T,Suzuki A,Kurahara Y,Shimatani Y,Matsushima H,Kusano K,Ohta H,Yanagisawa S,Kozu Y,Yui T,Igarashi S,Kimizuka Y,Honda K,Otani S,Chiba S,Xu DJ,Mitsui M,Waseda Y,Ishii H Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase Respiratory Investigation 2024 Nov;62(6):963-969.(倉原優)
72. Amano K,Koshimoto S,Okamura S,Sakaguchi T,Arakawa S,Matsuda Y,Tokoro A,Takeuchi T,Satomi E,Wada T,Wada M,Yamada T,Mori N Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer Healthcare 2024 Dec;12(24):(松田能宣)
73. Nii T, Fujiwara K, Kobayashi T, Hagiwara E, Fukushima K, Morimoto K, Tsuyuguchi K, Ogura T, Kida H. Serodiagnosis of M. abscessus species pulmonary disease using anti-glycopeptidolipid-core IgA antibody. IJTLD OPEN 2024 Dec;1(12):575－577.(露口一成)
74. Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease Journal of Infection and Chemotherapy 2025 Jan;31(1):102441.(倉原優)
75. Sugisaka J,Fujimoto D,Tamiya M,Hata A,Matsumoto H,Yokoyama T,Taniguchi Y,Uchida J,Sato Y,Kijima T,Tanaka H,Furuya N,Masuda T,Sakata Y,Miyauchi E,Saito G,Miura S,Yamaguchi T,Daga H,Sakata S,Yamamoto N,Akamatsu H Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study Lung Cancer 2025 Jan;199(谷口善彦)
76. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clinical Lung Cancer 2025 Jan;26(1):1-8.(田宮朗裕)
77. Horinouchi H,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Kozuki T,Tokito T,Oizumi S,Seike M,Ohashi K,Mio T,Sone T,Iwao C,Iwane T,Koto R,Tsuboi M Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study Lung Cancer 2025 Jan;199(安宅信二)
78. Arai T,Inoue Y,Akasaka K,Masunaga A,Fujita M,Yamaguchi E,Saigusa M,Murakami K,Kurahara Y,Tsuyuguchi K,Suzuki T,Miyazaki Y,Bando M,Suda T Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 2025 Jan;63(1):20-26.(新井徹)
79. Akapelwa M, Kapalamula T, Moonga L, Bwalya P, Solo E, Chizimu J, Thapa J, Hayashida K, Hang’ombe B, Munyeme M, Tamaru A, Wada W, Yoshida S, Kodera T, Kawase M, Gordon S, Yamada K, Nakajima C, Suzuki Y Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) method for differential detection of Mycobacterium bovis and Mycobacterium tuberculosis by dipstick DNA chromatography Microbiology Spectrum 2025 Jan 3;(𠮷田志緒美)
80. Inoue Y,Ogura T,Azuma A,Kondoh Y,Homma S,Muraishi K,Ikeda R,Ochiai K,Sugiyama Y,Nukiwa T Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy 2025 Feb;42(2):1075-1093.(井上義一)
81. Takashi Nishihara, Hideo Ishikawa, Kazunari Tsuyuguchi, Shoichi Fukuda, Hiromitsu Sumikawa Reevaluating the Role of Bronchoscopy Prior to Bronchial Artery Embolization in Non-Intubated Patients with Hemoptysis due to Bronchiectasis and Chronic Pulmonary Infection Chest Pulmonary 2025 Mar;online first(西原昂)
82. Takimoto T,Takeuchi N,Inoue Y,Arai T Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis PULMONOLOGY 2024 Sep 30;30(5):488-491.(滝本宜之)
83. Ozawa Y,Koh Y,Hase T,Chibana K,Kaira K,Okishio K,Ichihara E,Murakami S,Shimokawa M,Yamamoto N Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Therapeutic Advances in Medical Oncology 2024;16(沖塩協一)
84. Kurahara Y,Shimatani Y,Ryuge M,Tsuyuguchi K Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae Internal medicine 2024;63(6):879-880.(倉原優)
85. Kurahara Y Tuberculous Bronchostenosis Manifesting as the "CT Angiogram Sign" Internal medicine 2024;63(18):2581-2582.(倉原優)
和文原著・著書等
1. 田中 悠也, 倉原 優．病気のはなし 結核検査と技術2024;52(2): 124-128.
2. 松田 能宣．不安と呼吸困難呼吸器内科2024;45(4):422～426.
3. 倉原 優．論文視点 コロナ肺炎の後遺症3年後も3分の1に病変残存Medical Tribune2024;57(8):3.
4. 田中 悠也, 倉原 優, 嶋谷 泰明, 小林 岳彦, 吉田 志緒美, 松本 錦之介, 露口 一成．肺非結核性抗酸菌症から菌交代し肺結核を発症した症例の検討結核2024;99(3):154.
5. 倉原 優．膿性痰で分類されていたCOPD増悪の基準に下剋上J-IDEO2024;8(3):504-505.
6. 倉原 優．ポケット呼吸器診療2024シーニュ2024;
7. 露口一成．非結核性抗酸菌症の微生物学的検査の実際呼吸器内科2024;45(6):566-570.
8. 松田能宣．パニック発作
今夜からもう困らない！夜の症状緩和 南江堂2024;128～135.
9. 松田能宣．第Ⅳ章特定集団への緩和ケア 6慢性呼吸器疾患専門家をめざす人のための緩和医療学 南江堂2024;333～336.
10. 松田能宣．非がん慢性呼吸器疾患：エビデンスアップデート医学のあゆみ2024;289(10):771～775.
11. 倉原 優．エアロゾルと抗酸菌感染症呼吸器内科2024;45(6):623-628.
12. 倉原 優．なぜ右の横隔膜が弱いのか？J-IDEO2024;8(4):684-685.
13. 新井 徹．肺胞蛋白症呼吸器内科診療の掟2024;502～510.
14. 田中 悠也, 倉原 優パルスオキシメータ呼吸器ジャーナル2024;72376-378.
15. 田中 悠也, 倉原 優高高度における呼吸生理呼吸器ジャーナル2024;72392-394.
16. 田中 悠也, 倉原 優「Happy hypoxia」について再考する呼吸器ジャーナル2024;72491-493.
17. 倉原 優、森本耕三「世界気管支拡張症デー」広く病気の認知をJ-BREATH2024;(133):11.
18. 倉原 優．肺NTM症とエストロゲン枯渇J-IDEO2024;8(5):834-836.
19. 和田佐保、松田能宣、井上真一郎、角甲純、谷向仁【ガイドラインを実践できる,エビデンスと臨床のギャップが埋まる 向精神薬のエビデンスベースドプラクティス】(第2章)いまはこうする!ガイドラインのトリセツ せん妄(解説)薬事2024;66(14):2623-2629.
20. 松田能宣．【精神科医として関わるがん治療関連精神症状】進行がんにおける低活動型せん妄の診断と対応(解説)臨床精神薬理2024;27(10):1013-1021.
21. 𠮷田志緒美, 山本剛, 石井良和, 御手洗聡抗酸菌検査のアンケート調査2022における結果報告 結核2024;99(6):163-172.
22. 田中 悠也, 倉原 優喘息・COPD鑑別が難しい症例の問診・身体所見の実臨床でのコツ（検査に重きを置いて）. jmedmook94 今日の診療に活かせる喘息・COPD ポイント解説.今日の診療に活かせる 喘息・COPDポイント解説2024;
23. 倉原 優．慢性肺アスペルギルス症とイサブコナゾールJ-IDEO2024;8(6):982-984.
24. 露口一成．肺結核症最新ガイドラインに基づく呼吸器疾患診療指針2024;
25. 井上義一．リンパ脈管筋腫症最新ガイドラインに基づく呼吸器疾患診療指針 第６版2024;
26. 新井 徹．間質性肺炎の診断と地域連携Medical Practice2025;42(1):50～54.
27. 倉原 優．見逃したくない縦隔炎J-IDEO2025;9(1):62-64.
28. 𠮷田志緒美．検査材料抗酸菌検査ガイド20252025;31-36.
29. 井上義一．肺胞蛋白症呼吸器疾患最新の治療2025-20262025;
30. 蓮尾英明、松岡弘道、松田能宣緩和ケアにおける悩ましい感情のひも解き方Difficult Patient2025;
31. 倉原 優．「肺NTM症の診断基準」の改訂J-IDEO2025;9(2):282-283.
32. 𠮷田志緒美．病理組織標本で抗酸菌が観察されていますが，培養で発育しないと言われました．どのような抗酸菌を想定し，追加対応はどのようにすればよいでしょうか？臨床検査2025増大号 「さっと読めてぱっとわかる！感染症診断メモ」2025;69(4):
英文論文
1. A Yanagisawa, T Takimoto, Y Kurahara, K Tsuyuguchi, S Yoshida, M Hirose, Y Inoue, T Arai A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy Internal Medicine 2023 Nov;63(14):2043-2047.(柳澤篤)
2. Okuma Y,Kubota K,Shimokawa M,Hashimoto K,Kawashima Y,Sakamoto T,Wakui H,Murakami S,Okishio K,Hayashihara K,Ohe Y First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial JAMA Oncology 2024 Jan;10(1):43-51.(沖塩協一)
3. Tomioka H,Miyazaki Y,Inoue Y,Egashira R,Kawamura T,Sano H,Johkoh T,Takemura T,Hisada T,Fukuoka J,Comm Japanese Resp Soc Japane Japanese clinical practice guide 2022 for hypersensitivity pneumonitis Respiratory investigation 2024 Jan;62(1):16-43.(井上義一)
4. Tamiya A Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors Respiratory investigation 2024 Jan;62(1):85-89.(田宮朗裕)
5. Nishio M,Murakami S,Kawakami H,Okishio K,Tamiya M,Kobayashi H,Fujimoto D,Sugawara S,Kozuki T,Oya Y,Izumi H,Shiroyama T,Satouchi M,Yamamoto N,Kaname S,Matsuoka D,Otake Y,Takase T,Semba T,Azuma K Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort Cancer Research Communications 2024 Jan;4(1):226-235.(沖塩協一)
6. Matsumoto K,Shiroyama T,Tamiya M,Minami T,Kinehara Y,Tamiya A,Suga Y,Kuge T,Mori M,Suzuki H,Tobita S,Ueno K,Namba Y,Tetsumoto S,Niki T,Morimura O,Osa A,Nishino K,Nagatomo I,Takeda Y,Kijima T,Kumanogoh A Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study Cancer Immunology Immunotherapy 2024 Jan;73(1):(田宮朗裕)
7. Kobayashi T,Tsuyuguchi K,Shimatani Y,Matsuda Y,Kagawa T,Takimoto T,Takeuchi N,Arai T,Inoue Y Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis Journal of Infection and Chemotherapy 2024 Jan;30(1):7-11.(小林岳彦)
8. Walsh SLF, De Backer J, Prosch H, Langs G, Calandriello L, Cottin V, Brown KK, Inoue Y, Tzilas V, Estes E; Open Source Imaging Consortium (OSIC). Towards the adoption of quantitative computed tomography in the management of interstitial lung disease European Respiratory Review 2024 Jan 31;33(171):230055.(井上義一)
9. Shibaki R,Fujimoto D,Nozawa T,Sano A,Kitamura Y,Fukuoka J,Sato Y,Kijima T,Matsumoto H,Yokoyama T,Miura S,Hata A,Tamiya M,Taniguchi Y,Sugisaka J,Furuya N,Tanaka H,Yamamoto N,Koh Y,Akamatsu H Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2024 Feb;12(2):(谷口善彦)
10. Mitsudomi T,Ito H,Okada M,Sugawara S,Shio Y,Tomii K,Okami J,Sakakura N,Kubota K,Takamochi K,Atagi S,Tsuboi M,Oizumi S,Ikeda N,Ohde Y,Ntambwe I,Mahmood J,Cai JL,Tanaka F Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816 Cancer Science 2024 Feb;115(2):540-554.(安宅信二)
11. Ikeda S,Tsuboi M,Sakai K,Misumi T,Akamatsu H,Shoda H,Sakakura N,Nakamura A,Ohde Y,Hayashi H,Okishio K,Okada M,Yoshino I,Okami J,Takahashi K,Ikeda N,Tanahashi M,Tambo Y,Saito H,Toyooka S,Inokawa H,Chen-Yoshikawa T,Yokoyama T,Okamoto T,Yanagitani N,Oki M,Takahama M,Sawa K,Tada H,Nakagawa K,Mitsudomi T,Nishio K NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study Molecular Oncology 2024 Feb;18(2):305-316.(沖塩協一)
12. Kagawa T,Kurahashi K,Seki T,Kawasaki Y,Nahara I,Takeda C,Yonekura H,Tanaka S,Kawakami K The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database Journal of Anesthesia 2024 Feb;38(1):92-97.(香川智子)
13. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Taniguchi Y,Nosaki K,Fukumitsu K,Akechi T Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer Oncologist 2024 Feb 2;29(2):e282-e289.(松田能宣)
14. Akira M,Suganuma N Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia Canadian Respiratory Journal 2024 Feb 14;2024(審良正則)
15. Kurahara Y,Okamori H,Tsuyuguchi K A Large Cavity Associated with Pulmonary Infarction Internal medicine 2024 Mar;63(20):2867-2868.(倉原優)
16. Morimoto K,Nonaka M,Yamazaki Y,Nakagawa T,Takasaki J,Tsuyuguchi K,Kitada S,Jumadilova Z,Yuen DW,Ciesielska M,Hasegawa N Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study Respiratory investigation 2024 Mar;62(2):284-290.(露口一成)
17. Molina TJ,Roden AC,Szolkowska M,Shimizu S,Moreira AL,Chalabreysse L,Besse B,de Montpr V,Marom EM,Detterback F,Girard N,Nicholson AG,Marx A International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study Lung Cancer 2024 Mar;189(清水重喜)
18. Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry. JACC-ASIA 2024 Mar;4(5):403-417.(井上義一)
19. Isobe K,Nakamura Y,Sakamoto S,Tomii K,Takimoto T,Miyazaki Y,Matsumoto M,Sugino K,Ichikado K,Moriguchi S,Yamaguchi K,Baba T,Ozasa H,Igata F,Anabuki K,Homma S,Date H,Suda T,Kishi K Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia ERJ Open Research 2024 Mar 1;10(2):(滝本宜之)
20. Richeldi L,Schiffman C,Behr J,Inoue Y,Corte TJ,Cottin V,Jenkins RG,Nathan SD,Raghu G,Walsh SLF,Jayia PK,Kamath N,Martinez FJ Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial American Journal of Respiratory and Critical Care Medicine 2024 May 1;209(9):1132-1140.(井上義一)
21. Wada T,Yoshida S,Yamamoto T,Nonaka L,Fukushima Y,Nakajima C,Suzuki Y,Imajoh M Application of Genomic Epidemiology of Pathogens to Farmed Yellowtail Fish Mycobacteriosis in Kyushu, Japan Microbes and Environments 2024;39(2):ME24011.(𠮷田志緒美)
22. Amano K,Baracos VE,Mori N,Okamura S,Yamada T,Miura T,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer Clinical Nutrition ESPEN 2024 Apr;60313-319.(松田能宣)
23. Enomoto N,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Aono Y,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Sano T,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Nakamura Y,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study Respiratory Medicine 2024 Apr;224(澄川裕充)
24. Kanemura H,Yokoyama T,Nakajima R,Nakamura A,Kuroda H,Kitamura Y,Shoda H,Mamesaya N,Miyata Y,Okamoto T,Okishio K,Oki M,Sakairi Y,Chen-Yoshikawa TF,Aoki T,Ohira T,Matsumoto I,Ueno K,Miyazaki T,Matsuguma H,Yokouchi H,Otani T,Ito A,Sakai K,Chiba Y,Nishio K,Yamamoto N,Okamoto I,Nakagawa K,Takeda M The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma JTO CLINICAL AND RESEARCH REPORTS 2024 Apr;5(4):(沖塩協一)
25. Kako J,Kajiwara K,Kobayashi M,Kanno Y,Morikawa M,Nakano K,Matsuda Y,Shimizu Y,Niino M,Suzuki M,Shimazu T Applicability of Nursing Support for Patients With Terminal Cancer and Their Families: A Delphi Study AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE 2024 Apr 5;42(2):145-154.(松田能宣)
26. Hasegawa T,Mori M,Yamaguchi T,Imai K,Matsuda Y,Maeda I,Hatano Y,Yokomichi N,Hamano J,Morita T Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study Journal of Palliative Medicine 2024 Dec 5;(松田能宣)
27. Shimaya M,Inagaki Y,Arai T,Kawakami M,Takeuchi N,Sumikawa H,Shimizu S,Takimoto T,Inoue Y Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome Internal medicine 2024 May;63(10):1451-1457.(島矢未奈子)
28. Taniguchi Y,Arai T,Tsuji T,Sugimoto C,Tachibana K,Akira M,Inoue Y Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases Journal of Thoracic Disease 2024 May;16(5):3129-+.(谷口善彦)
29. Hoshida Y,Tsujii A,Ohshima S,Saeki Y,Yagita M,Miyamura T,Katayama M,Kawasaki T,Hiramatsu Y,Oshima H,Murayama T,Higa S,Kuraoka K,Hirano F,Ichikawa K,Kurosawa M,Suzuki H,Chiba N,Sugiyama T,Minami Y,Niino H,Ihata A,Saito I,Mitsuo A,Maejima T,Kawashima A,Tsutani H,Takahi K,Kasai T,Shinno Y,Tachiyama Y,Teramoto N,Taguchi K,Naito S,Yoshizawa S,Ito M,Suenaga Y,Mori S,Nagakura S,Yoshikawa N,Nomoto M,Ueda A,Nagaoka S,Tsuura Y,Setoguchi K,Sugii S,Abe A,Sugaya T,Sugahara H,Fujita S,Kunugiza Y,Iizuka N,Yoshihara R,Yabe H,Fujisaki T,Morii E,Takeshita M,Sato M,Saito K,Matsui K,Tomita Y,Furukawa H,Tohma S Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders Arthritis & rheumatology 2024 Jun 10;76(6):869-881.(笠井孝彦)
30. Kurahara Y,Shimatani Y Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection JMA Journal 2024 Jul 16;7(3):441-442.(倉原優)
31. Amano K,Okamura S,Matsuda Y,Baracos VE,Mori N,Miura T,Tatara R,Kessoku T,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with depression in patients with advanced cancer Supportive Care in Cancer 2024 Jul;32(7):(松田能宣)
32. Sakurai T,Kanou T,Funaki S,Fukui E,Kimura T,Ose N,Inoue Y,Shintani Y Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study Respiratory investigation 2024 Jul;62(4):657-662.(井上義一)
33. Inoue Y,Kitamura H,Okamoto M,Ogura T,Nishioka Y,Kuwana M,Taniguchi A,Ito T,Rohr KB,Suda T The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial Respiratory investigation 2024 Jul;62(4):589-596.(井上義一)
34. Tsuboi M,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Tokito T,Mio T,Adachi H,Kozuki T,Sone T,Seike M,Toyooka S,Kitagawa H,Koto R,Yamazaki S,Horinouchi H Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study Thoracic cancer 2024 Jul;15(20):1541-1552.(安宅信二)
35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Inagaki Y,Nosaki K,Fukumitsu K,Akechi T Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer Supportive Care in Cancer 2024 Jul;32(7):(稲垣雄士)
36. Miwa S,Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigators Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study Palliative Medicine Reports 2024 Jul 1;5(1):225-233.(松田能宣)
37. Kojima K,Samejima H,Iguchi T,Tokunaga T,Okishio K,Yoon H Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer Scientific reports 2024 Jul 4;14(1):(小島健介)
38. Enomoto T,Shirai Y,Takeda Y,Edahiro R,Shichino S,Nakayama M,Takahashi-Itoh M,Noda Y,Adachi Y,Kawasaki T,Koba T,Futami Y,Yaga M,Hosono Y,Yoshimura H,Amiya S,Hara R,Yamamoto M,Nakatsubo D,Suga Y,Naito M,Masuhiro K,Hirata H,Iwahori K,Nagatomo I,Miyake K,Koyama S,Fukushima K,Shiroyama T,Naito Y,Futami S,Natsume-Kitatani Y,Nojima S,Yanagawa M,Shintani Y,Nogami-Itoh M,Mizuguchi K,Adachi J,Tomonaga T,Inoue Y,Kumanogoh A SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis Takatoshi Enomoto, ... , Yoshikazu Inoue, Atsushi Kumanogoh JCI Insight 2024 Jul 10;9(11):(井上義一)
39. Nakano K,Kanno Y,Kajiwara K,Kobayashi M,Morikawa M,Matsuda Y,Shimizu Y,Shimazu T,Kako J Nursing Support for Constipation in Patients with Cancer: A Scoping Review Journal of Palliative Medicine 2024 Jul 29;28(1):115-122.(松田能宣)
40. Kurahara Y,Tanaka Y,Kobayashi T,Yoshida S,Tsuyuguchi K Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease Journal of Infection and Chemotherapy 2024 Aug;30(8):780-784.(倉原優)
41. Hamamoto Y,Kawamura M,Uchida H,Hiramatsu K,Katori C,Asai H,Shimizu S,Egawa S,Yoshida K The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model International Journal of Surgical Pathology 2024 Aug;32(5):890-894.(清水重喜)
42. Shimizu M,Maeda I,Kessoku T,Ishiki H,Matsuura T,Hiratsuka Y,Matsuda Y,Hasegawa T,Imai K,Oyamada S,Satomi E The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study Supportive Care in Cancer 2024 Aug;32(8):(松田能宣)
43. Yaga M,Hasegawa K,Ikeda S,Matsubara M,Hiroshima T,Kimura T,Shirai Y,Tansri W,Uehara H,Tachikawa M,Okairi Y,Sone M,Mori H,Kogue Y,Akamine H,Okuzaki D,Kawagishi K,Kawanaka S,Yamato H,Takeuchi Y,Okura E,Kanzaki R,Okami J,Nakamichi I,Nakane S,Kobayashi A,Iwazawa T,Tokunaga T,Yokouchi H,Yano Y,Uchida J,Mori M,Komuta K,Tachi T,Kuroda H,Kijima N,Kishima H,Ichii M,Futami S,Naito Y,Shiroyama T,Miyake K,Koyama S,Hirata H,Takeda Y,Funaki S,Shintani Y,Kumanogoh A,Hosen N CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy Scientific reports 2024 Aug 2;14(1):(德永俊照)
44. Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status BMC Pulmonary Medicine 2024 Aug 24;24(24):407.(谷口善彦)
45. Takimoto T, Sumikawa H, Inoue Y, Arai T. Auto-Fluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Auto-Fluorescence Sign. American Journal of Respiratory and Critical Care Medicine 2024 Sep;210(5):665-668.(滝本宜之)
46. Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy Thoracic Cancer 2024 Sep;15(26):1882-1888.(露口一成)
47. Tanaka Y,Kobayashi T,Shimizu S,Kurahara Y Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug Internal medicine 2024 Sep;63(18):2587-2588.(田中悠也)
48. Ueno M,Egashira R,Hashisako M,Fujimoto K,Fukuda T,Hayashida Y,Sumikawa H,Tominaga J,Tanaka T,Terasaki Y,Fukuoka J,Nishioka Y,Aoki T,Gabata T,Hatabu H,Johkoh T Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence Japanese Journal of Radiology 2024 Sep;42(9):993-1002.(澄川裕充)
49. Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer 2024 Sep;195107917.(田宮朗裕)
50. Moda M,Sumikawa H,Shintani R,Takeuchi N,Kagawa T,Takimoto T,Arai T Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease Respiratory investigation 2024 Sep;62(5):872-878.(茂田光弘)
51. Matsumoto K,Yamamoto Y,Shiroyama T,Kuge T,Mori M,Tamiya M,Kinehara Y,Tamiya A,Suzuki H,Tobita S,Ueno K,Niki T,Nagatomo I,Takeda Y,Kumanogoh A Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study Targeted Oncology 2024 Sep;19(5):757-767.(田宮朗裕)
52. Takimoto T,Sumikawa H,Inoue Y,Arai T Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome Negative Autofluorescence Sign American Journal of Respiratory and Critical Care Medicine 2024 Sep 1;210(5):665-668.(滝本宜之)
53. Enomoto N,Nakai S,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Fujii M,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Nakamura Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study Respiratory Research 2024 Sep 28;25(1):(澄川裕充)
54. Kojima K,Samejima H,Okishio K,Tokunaga T,Yoon H,Atagi S Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study BMJ Open Respiratory Research 2024 Sep 28;11(1):(小島健介)
55. Kubo K,Sakuraya M,Sugimoto H,Takahashi N,Kano K,Yoshimura J,Egi M,Kondo Y Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis Critical Care Medicine 2024 Oct;52(10):e522-e534.(杉本裕史)
56. Shibaki R,Fujimoto D,Miyauchi E,Tsukita Y,Nakachi I,Arai D,Sakata Y,Shingu N,Shimokawa T,Kijima T,Tamiya M,Kawana S,Harai S,Saito G,Sato Y,Yokoyama T,Sakata S,Taniguchi Y,Hata A,Matsumoto H,Yamaguchi T,Yamamoto N Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial Lung Cancer 2024 Oct;196(谷口善彦)
57. Tsukaguchi A,Tamiya A,Fukuda S,Iwahashi Y,Kanaoka K,Tanaka Y,Inagaki Y,Taniguchi Y,Nakao K,Kagawa T,Matsuda Y,Okishio K Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer Anticancer Research 2024 Oct;44(10):4517-4524.(塚口晃洋)
58. Sumikawa H,Johkoh T,Egashira R,Sugiura H,Sugimoto C,Tanaka T,Nakamura M,Kuriu A,Tomiyama N,Fujisawa T,Nakamura Y,Suda T Variability of radiological and clinical features in cases with usual interstitial pneumonia without honeycombing European Journal of Radiology 2024 Oct;179(澄川裕充)
59. Wijsenbeek MS,Swigris JJ,Spagnolo P,Kolb M,Kreuter M,Nunes H,Stansen W,Rohr KB,Inoue Y,INBUILD Trial Investigators Worsening dyspnoea as a predictor of progression of pulmonary fibrosis European Respiratory Journal 2024 Oct;64(4):(井上義一)
60. Kako J,Morikawa M,Kajiwara K,Kobayashi M,Kanno Y,Nakano K,Matsuda Y Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan Palliative Medicine Reports 2024 Oct 1;5(1):440-444.(松田能宣)
61. Yamaguchi T,Matsuda Y,Watanabe H,Kako J,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,JSPM Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine Journal of Palliative Medicine 2024 Oct 1;27(10):1404-1414.(松田能宣)
62. Kajiwara K,Kobayashi M,Nakano K,Kanno Y,Morikawa M,Matsuda Y,Kako J Use of Nursing Support Among Nurses for Caregiver Burden in Family Caregivers of Terminally Ill Patients with Cancer in Palliative Care Units in Japan: Multisite Cross-Sectional Study Palliative Medicine Reports 2024 Oct 1;5(1):425-429.(松田能宣)
63. Sakura K,Kuroyama M,Shintani Y,Funaki S,Atagi S,Kadota Y,Kuribayashi K,Kijima T,Nakano T,Nakajima T,Sasai M,Okumura M,Kaneda Y Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial Cancer Immunology Immunotherapy 2024 Oct 3;73(12):(安宅信二)
64. Hasuo H,Ishiki H,Matsuda Y,Matsuoka H,Kosugi K,Xing M,Akiyama Y,Matsumoto Y,Ishikawa H Trigger point injections for myofascial pain in terminal cancer: a randomized trial Pain Medicine 2024 Oct 12;26(1):14-21.(松田能宣)
65. Kondoh Y,Furukawa T,Hozumi H,Suda T,Egashira R,Jokoh T,Fukuoka J,Kuwana M,Teramachi R,Fujisawa T,Hasegawa Y,Ogura T,Miyazaki Y,Oyama S,Teramukai S,Horiguchi G,Naito A,Inoue Y,Ichikado K,Bando M,Tomioka H,Nishioka Y,Chiba H,Ebina M,Nakanishi Y,Satoh K,Shiratori Y,Hashimoto N,Ishii M The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis BMC pulmonary medicine 2024 Oct 14;24(1):(井上義一)
66. Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU; representatives of the sarcoidosis community: Nicole Goh, Anne Holland, Johann Hochreiter, Selene Kock, Karolien Verheyen, Johan Verbraecken, André Cantin, Ashley Gillson, Nathan Hambly, Martin Kolb, Elisabeth Bendstrup, Anna Leistiko, Janne Møller, Riitta Kaarteenaho, Bruno Crestani, Dominique Israël-Biet, Fleur Cohen Aubart, Hilario Nunes, Dominique Valeyre, Francesco Bonella, Katharina Buschulte, Ulrich Costabel, Peter Kortsen, Michael Kreuter, Peter Luedike, Bernd Quadder, Renate Braune, Dirk Skowasch, Katerina Antoniou, Demosthenes Bouros, Athena Gogali, George A Margaritopoulos, Despoina Papakosta, Spyros A Papiris, Effrosyni D Manali, Argyris Tzouvelekis, Vasilios Tzilas, Aditya Agrawal, Surender Kashyap, Vijay Narain Tyagi, Desai Unnati, Atefeh Abedini, Sean Phelan, Elena Bargagli, Francesco Cinetto, Marco Confalonieri, Paola Confalonieri, Sergio Harari, Fabrizio Luppi, Filippo Martone, Anna Palmieri, Paola Rottoli, Francesco Salton, Ricardo Scarpa, Claudio Tana, Sara Tomassetti, Arata Azuma, Naoki Inui, Yutaro Nakamura, Yoshikazu Inoue, Yoshinori Tanino, Noorul Afidza Muhammad, Frouke van Beek, Lenze den Boer, Karin Boomars, Paul Bresser, Laura Claessen, Marjon Elfferich, Roel Erckens, Sanne van Helmondt, Bekir Karakaya, Jan C Grutters, Elske Hoitsma, Károly Illy, Tim L Jansen, Vivienne Kahlmann, Chris Knoet, Ingrid Korenromp, Ton Lenssen, Karen Maassen Vd Brinkdrs, Johannes Jurgen Mager, Rik Marcellis, Jelle Miedema, Trudeke Möller, Linda A A Moonen, Karen Moor, Rémy L M Mostard, Willemien Nienhuis, Esther Nossent, Michelle Paulus, Rudolf Ponds, George Nossent, Marian Quanjel, Felix Rottenberg, Jonathan S O van de Sande, Ruud Segers, Shalini D Soechitram, AnneLoes van Staa, Bert Strookappe, Martin Swaans, Leon van den Toorn, Marjo J T van de Ven, Mareye Voortman, Adriane Dore Marie Vorselaars, Lenneke Vente, Petal A Wijnen, Marlies Wijsenbeek, Jolanda De Vries, Arthur van Zanten, Michael Durheim, Øystein Rasch-Halvorsen, Anders Tøndell, Anna Dubaniewicz, Wojciech Piotrowski, Bartlomiej Roter, Carlos Robalo Cordeiro, Tiago Alfaro, Irina Strambu, Alexander Vizel, Rafael Cano, Eva Balcells, Diego Castillo, Joel Francesqui, Juan Mañá, Maria Molina, Inigo Ojanguren, Jose Antonio Rodriguez Portal, Jacobo Sellares, Elizabeth Arkema, Pernilla Darlington, Per Eldhagen, Katinka Elfström, Johan Grunewald, Susanna Kullberg, Natalia V Rivera, Marios Rossides, Joanna Werner, Irem Dincer, Gülcan Koç, Canan Yucesan, Ozlem Ozdemir Kumbasar, Surinder Birring, Jeanette Boyd, Leo Casimo, Christopher Huntley, Vasileios Kouranos, Jaqui Newton, Lisa Spencer, Mark Spears, Paula Barreras, Yvette Cozier, Elliott Crouser, Logan Harper, W Ennis James, Lisa Maier, Shu-Yi Liao, Adam Morgenthau, Ogugua Ndili Obi, Divya Patel, Frank Rivera, Milton D Rossman, Michelle Sharp, Maggie Sharma, Jonas C Schupp, Barney J Stern, Nadera Sweiss, Jinny Tavee, Daniel Zank, Galyna Gumeniuk, Volodymyr Gavrysyuk, Levgeniia Merenkova. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis Lancet Respiratory Medicine 2024 Nov;12(11):848-851.(井上義一)
67. Kako J,Kobayashi M,Matsuda Y,Inoue S,Tanimukai H,Wada S,Hasegawa T Nonpharmacological Intervention for Delirium in Patients With Cancer: A Scoping Review Journal of Pain and Symptom Management 2024 Nov;68(5):(松田能宣)
68. Kanaoka K,Arai T,Takimoto T,Moda M,Shintani R,Ryuge M,Takeuchi N,Kagawa T,Tachibana K,Inoue Y,Sumikawa H,Takeda M,Shimizu S Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study Respiratory investigation 2024 Nov;62(6):1161-1167.(金岡賢輔)
69. Kawachi H,Tamiya M,Oya Y,Saito G,Taniguchi Y,Matsumoto H,Sato Y,Otsuki T,Suzuki H,Fukuda Y,Tanaka S,Tsukita Y,Uchida J,Sakata Y,Nakatani Y,Shibaki R,Arai D,Okada A,Hara S,Takayama K,Nishino K Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005) Clinical Lung Cancer 2024 Nov;25(7):643-652.(谷口善彦)
70. Yoshida S,Tsuyuguchi K,Kobayashi T,Kurahara Y,Shimatani Y,Arai T Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease Respiratory Investigation 2024 Nov;62(6):1142-1148.(𠮷田志緒美)
71. Shimoda M,Tanaka Y,Ohe T,Ishiguro T,Suzuki A,Kurahara Y,Shimatani Y,Matsushima H,Kusano K,Ohta H,Yanagisawa S,Kozu Y,Yui T,Igarashi S,Kimizuka Y,Honda K,Otani S,Chiba S,Xu DJ,Mitsui M,Waseda Y,Ishii H Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase Respiratory Investigation 2024 Nov;62(6):963-969.(倉原優)
72. Amano K,Koshimoto S,Okamura S,Sakaguchi T,Arakawa S,Matsuda Y,Tokoro A,Takeuchi T,Satomi E,Wada T,Wada M,Yamada T,Mori N Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer Healthcare 2024 Dec;12(24):(松田能宣)
73. Nii T, Fujiwara K, Kobayashi T, Hagiwara E, Fukushima K, Morimoto K, Tsuyuguchi K, Ogura T, Kida H. Serodiagnosis of M. abscessus species pulmonary disease using anti-glycopeptidolipid-core IgA antibody. IJTLD OPEN 2024 Dec;1(12):575－577.(露口一成)
74. Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease Journal of Infection and Chemotherapy 2025 Jan;31(1):102441.(倉原優)
75. Sugisaka J,Fujimoto D,Tamiya M,Hata A,Matsumoto H,Yokoyama T,Taniguchi Y,Uchida J,Sato Y,Kijima T,Tanaka H,Furuya N,Masuda T,Sakata Y,Miyauchi E,Saito G,Miura S,Yamaguchi T,Daga H,Sakata S,Yamamoto N,Akamatsu H Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study Lung Cancer 2025 Jan;199(谷口善彦)
76. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clinical Lung Cancer 2025 Jan;26(1):1-8.(田宮朗裕)
77. Horinouchi H,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Kozuki T,Tokito T,Oizumi S,Seike M,Ohashi K,Mio T,Sone T,Iwao C,Iwane T,Koto R,Tsuboi M Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study Lung Cancer 2025 Jan;199(安宅信二)
78. Arai T,Inoue Y,Akasaka K,Masunaga A,Fujita M,Yamaguchi E,Saigusa M,Murakami K,Kurahara Y,Tsuyuguchi K,Suzuki T,Miyazaki Y,Bando M,Suda T Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 2025 Jan;63(1):20-26.(新井徹)
79. Akapelwa M, Kapalamula T, Moonga L, Bwalya P, Solo E, Chizimu J, Thapa J, Hayashida K, Hang’ombe B, Munyeme M, Tamaru A, Wada W, Yoshida S, Kodera T, Kawase M, Gordon S, Yamada K, Nakajima C, Suzuki Y Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) method for differential detection of Mycobacterium bovis and Mycobacterium tuberculosis by dipstick DNA chromatography Microbiology Spectrum 2025 Jan 3;(𠮷田志緒美)
80. Inoue Y,Ogura T,Azuma A,Kondoh Y,Homma S,Muraishi K,Ikeda R,Ochiai K,Sugiyama Y,Nukiwa T Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy 2025 Feb;42(2):1075-1093.(井上義一)
81. Takashi Nishihara, Hideo Ishikawa, Kazunari Tsuyuguchi, Shoichi Fukuda, Hiromitsu Sumikawa Reevaluating the Role of Bronchoscopy Prior to Bronchial Artery Embolization in Non-Intubated Patients with Hemoptysis due to Bronchiectasis and Chronic Pulmonary Infection Chest Pulmonary 2025 Mar;online first(西原昂)
82. Takimoto T,Takeuchi N,Inoue Y,Arai T Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis PULMONOLOGY 2024 Sep 30;30(5):488-491.(滝本宜之)
83. Ozawa Y,Koh Y,Hase T,Chibana K,Kaira K,Okishio K,Ichihara E,Murakami S,Shimokawa M,Yamamoto N Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Therapeutic Advances in Medical Oncology 2024;16(沖塩協一)
84. Kurahara Y,Shimatani Y,Ryuge M,Tsuyuguchi K Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae Internal medicine 2024;63(6):879-880.(倉原優)
85. Kurahara Y Tuberculous Bronchostenosis Manifesting as the "CT Angiogram Sign" Internal medicine 2024;63(18):2581-2582.(倉原優)
和文原著・著書等
1. 田中 悠也, 倉原 優．病気のはなし 結核検査と技術2024;52(2): 124-128.
2. 松田 能宣．不安と呼吸困難呼吸器内科2024;45(4):422～426.
3. 倉原 優．論文視点 コロナ肺炎の後遺症3年後も3分の1に病変残存Medical Tribune2024;57(8):3.
4. 田中 悠也, 倉原 優, 嶋谷 泰明, 小林 岳彦, 吉田 志緒美, 松本 錦之介, 露口 一成．肺非結核性抗酸菌症から菌交代し肺結核を発症した症例の検討結核2024;99(3):154.
5. 倉原 優．膿性痰で分類されていたCOPD増悪の基準に下剋上J-IDEO2024;8(3):504-505.
6. 倉原 優．ポケット呼吸器診療2024シーニュ2024;
7. 露口一成．非結核性抗酸菌症の微生物学的検査の実際呼吸器内科2024;45(6):566-570.
8. 松田能宣．パニック発作
今夜からもう困らない！夜の症状緩和 南江堂2024;128～135.
9. 松田能宣．第Ⅳ章特定集団への緩和ケア 6慢性呼吸器疾患専門家をめざす人のための緩和医療学 南江堂2024;333～336.
10. 松田能宣．非がん慢性呼吸器疾患：エビデンスアップデート医学のあゆみ2024;289(10):771～775.
11. 倉原 優．エアロゾルと抗酸菌感染症呼吸器内科2024;45(6):623-628.
12. 倉原 優．なぜ右の横隔膜が弱いのか？J-IDEO2024;8(4):684-685.
13. 新井 徹．肺胞蛋白症呼吸器内科診療の掟2024;502～510.
14. 田中 悠也, 倉原 優パルスオキシメータ呼吸器ジャーナル2024;72376-378.
15. 田中 悠也, 倉原 優高高度における呼吸生理呼吸器ジャーナル2024;72392-394.
16. 田中 悠也, 倉原 優「Happy hypoxia」について再考する呼吸器ジャーナル2024;72491-493.
17. 倉原 優、森本耕三「世界気管支拡張症デー」広く病気の認知をJ-BREATH2024;(133):11.
18. 倉原 優．肺NTM症とエストロゲン枯渇J-IDEO2024;8(5):834-836.
19. 和田佐保、松田能宣、井上真一郎、角甲純、谷向仁【ガイドラインを実践できる,エビデンスと臨床のギャップが埋まる 向精神薬のエビデンスベースドプラクティス】(第2章)いまはこうする!ガイドラインのトリセツ せん妄(解説)薬事2024;66(14):2623-2629.
20. 松田能宣．【精神科医として関わるがん治療関連精神症状】進行がんにおける低活動型せん妄の診断と対応(解説)臨床精神薬理2024;27(10):1013-1021.
21. 𠮷田志緒美, 山本剛, 石井良和, 御手洗聡抗酸菌検査のアンケート調査2022における結果報告 結核2024;99(6):163-172.
22. 田中 悠也, 倉原 優喘息・COPD鑑別が難しい症例の問診・身体所見の実臨床でのコツ（検査に重きを置いて）. jmedmook94 今日の診療に活かせる喘息・COPD ポイント解説.今日の診療に活かせる 喘息・COPDポイント解説2024;
23. 倉原 優．慢性肺アスペルギルス症とイサブコナゾールJ-IDEO2024;8(6):982-984.
24. 露口一成．肺結核症最新ガイドラインに基づく呼吸器疾患診療指針2024;
25. 井上義一．リンパ脈管筋腫症最新ガイドラインに基づく呼吸器疾患診療指針 第６版2024;
26. 新井 徹．間質性肺炎の診断と地域連携Medical Practice2025;42(1):50～54.
27. 倉原 優．見逃したくない縦隔炎J-IDEO2025;9(1):62-64.
28. 𠮷田志緒美．検査材料抗酸菌検査ガイド20252025;31-36.
29. 井上義一．肺胞蛋白症呼吸器疾患最新の治療2025-20262025;
30. 蓮尾英明、松岡弘道、松田能宣緩和ケアにおける悩ましい感情のひも解き方Difficult Patient2025;
31. 倉原 優．「肺NTM症の診断基準」の改訂J-IDEO2025;9(2):282-283.
32. 𠮷田志緒美．病理組織標本で抗酸菌が観察されていますが，培養で発育しないと言われました．どのような抗酸菌を想定し，追加対応はどのようにすればよいでしょうか？臨床検査2025増大号 「さっと読めてぱっとわかる！感染症診断メモ」2025;69(4):2024年度
英文論文
1. A Yanagisawa, T Takimoto, Y Kurahara, K Tsuyuguchi, S Yoshida, M Hirose, Y Inoue, T Arai A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy Internal Medicine 2023 Nov;63(14):2043-2047.(柳澤篤)
2. Okuma Y,Kubota K,Shimokawa M,Hashimoto K,Kawashima Y,Sakamoto T,Wakui H,Murakami S,Okishio K,Hayashihara K,Ohe Y First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations The UNICORN Phase 2 Nonrandomized Clinical Trial JAMA Oncology 2024 Jan;10(1):43-51.(沖塩協一)
3. Tomioka H,Miyazaki Y,Inoue Y,Egashira R,Kawamura T,Sano H,Johkoh T,Takemura T,Hisada T,Fukuoka J,Comm Japanese Resp Soc Japane Japanese clinical practice guide 2022 for hypersensitivity pneumonitis Respiratory investigation 2024 Jan;62(1):16-43.(井上義一)
4. Tamiya A Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors Respiratory investigation 2024 Jan;62(1):85-89.(田宮朗裕)
5. Nishio M,Murakami S,Kawakami H,Okishio K,Tamiya M,Kobayashi H,Fujimoto D,Sugawara S,Kozuki T,Oya Y,Izumi H,Shiroyama T,Satouchi M,Yamamoto N,Kaname S,Matsuoka D,Otake Y,Takase T,Semba T,Azuma K Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort Cancer Research Communications 2024 Jan;4(1):226-235.(沖塩協一)
6. Matsumoto K,Shiroyama T,Tamiya M,Minami T,Kinehara Y,Tamiya A,Suga Y,Kuge T,Mori M,Suzuki H,Tobita S,Ueno K,Namba Y,Tetsumoto S,Niki T,Morimura O,Osa A,Nishino K,Nagatomo I,Takeda Y,Kijima T,Kumanogoh A Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study Cancer Immunology Immunotherapy 2024 Jan;73(1):(田宮朗裕)
7. Kobayashi T,Tsuyuguchi K,Shimatani Y,Matsuda Y,Kagawa T,Takimoto T,Takeuchi N,Arai T,Inoue Y Utility of a loop-mediated isothermal amplification detection kit to diagnose chronic pulmonary aspergillosis Journal of Infection and Chemotherapy 2024 Jan;30(1):7-11.(小林岳彦)
8. Walsh SLF, De Backer J, Prosch H, Langs G, Calandriello L, Cottin V, Brown KK, Inoue Y, Tzilas V, Estes E; Open Source Imaging Consortium (OSIC). Towards the adoption of quantitative computed tomography in the management of interstitial lung disease European Respiratory Review 2024 Jan 31;33(171):230055.(井上義一)
9. Shibaki R,Fujimoto D,Nozawa T,Sano A,Kitamura Y,Fukuoka J,Sato Y,Kijima T,Matsumoto H,Yokoyama T,Miura S,Hata A,Tamiya M,Taniguchi Y,Sugisaka J,Furuya N,Tanaka H,Yamamoto N,Koh Y,Akamatsu H Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER 2024 Feb;12(2):(谷口善彦)
10. Mitsudomi T,Ito H,Okada M,Sugawara S,Shio Y,Tomii K,Okami J,Sakakura N,Kubota K,Takamochi K,Atagi S,Tsuboi M,Oizumi S,Ikeda N,Ohde Y,Ntambwe I,Mahmood J,Cai JL,Tanaka F Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816 Cancer Science 2024 Feb;115(2):540-554.(安宅信二)
11. Ikeda S,Tsuboi M,Sakai K,Misumi T,Akamatsu H,Shoda H,Sakakura N,Nakamura A,Ohde Y,Hayashi H,Okishio K,Okada M,Yoshino I,Okami J,Takahashi K,Ikeda N,Tanahashi M,Tambo Y,Saito H,Toyooka S,Inokawa H,Chen-Yoshikawa T,Yokoyama T,Okamoto T,Yanagitani N,Oki M,Takahama M,Sawa K,Tada H,Nakagawa K,Mitsudomi T,Nishio K NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study Molecular Oncology 2024 Feb;18(2):305-316.(沖塩協一)
12. Kagawa T,Kurahashi K,Seki T,Kawasaki Y,Nahara I,Takeda C,Yonekura H,Tanaka S,Kawakami K The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality: A retrospective observational study using a Japanese claims database Journal of Anesthesia 2024 Feb;38(1):92-97.(香川智子)
13. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Taniguchi Y,Nosaki K,Fukumitsu K,Akechi T Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer Oncologist 2024 Feb 2;29(2):e282-e289.(松田能宣)
14. Akira M,Suganuma N Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibrotic Nonspecific Interstitial Pneumonia Canadian Respiratory Journal 2024 Feb 14;2024(審良正則)
15. Kurahara Y,Okamori H,Tsuyuguchi K A Large Cavity Associated with Pulmonary Infarction Internal medicine 2024 Mar;63(20):2867-2868.(倉原優)
16. Morimoto K,Nonaka M,Yamazaki Y,Nakagawa T,Takasaki J,Tsuyuguchi K,Kitada S,Jumadilova Z,Yuen DW,Ciesielska M,Hasegawa N Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study Respiratory investigation 2024 Mar;62(2):284-290.(露口一成)
17. Molina TJ,Roden AC,Szolkowska M,Shimizu S,Moreira AL,Chalabreysse L,Besse B,de Montpr V,Marom EM,Detterback F,Girard N,Nicholson AG,Marx A International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study Lung Cancer 2024 Mar;189(清水重喜)
18. Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry. JACC-ASIA 2024 Mar;4(5):403-417.(井上義一)
19. Isobe K,Nakamura Y,Sakamoto S,Tomii K,Takimoto T,Miyazaki Y,Matsumoto M,Sugino K,Ichikado K,Moriguchi S,Yamaguchi K,Baba T,Ozasa H,Igata F,Anabuki K,Homma S,Date H,Suda T,Kishi K Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia ERJ Open Research 2024 Mar 1;10(2):(滝本宜之)
20. Richeldi L,Schiffman C,Behr J,Inoue Y,Corte TJ,Cottin V,Jenkins RG,Nathan SD,Raghu G,Walsh SLF,Jayia PK,Kamath N,Martinez FJ Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis The Randomized Phase III STARSCAPE Trial American Journal of Respiratory and Critical Care Medicine 2024 May 1;209(9):1132-1140.(井上義一)
21. Wada T,Yoshida S,Yamamoto T,Nonaka L,Fukushima Y,Nakajima C,Suzuki Y,Imajoh M Application of Genomic Epidemiology of Pathogens to Farmed Yellowtail Fish Mycobacteriosis in Kyushu, Japan Microbes and Environments 2024;39(2):ME24011.(𠮷田志緒美)
22. Amano K,Baracos VE,Mori N,Okamura S,Yamada T,Miura T,Tatara R,Kessoku T,Matsuda Y,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer Clinical Nutrition ESPEN 2024 Apr;60313-319.(松田能宣)
23. Enomoto N,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Aono Y,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Sano T,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Nakamura Y,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study Respiratory Medicine 2024 Apr;224(澄川裕充)
24. Kanemura H,Yokoyama T,Nakajima R,Nakamura A,Kuroda H,Kitamura Y,Shoda H,Mamesaya N,Miyata Y,Okamoto T,Okishio K,Oki M,Sakairi Y,Chen-Yoshikawa TF,Aoki T,Ohira T,Matsumoto I,Ueno K,Miyazaki T,Matsuguma H,Yokouchi H,Otani T,Ito A,Sakai K,Chiba Y,Nishio K,Yamamoto N,Okamoto I,Nakagawa K,Takeda M The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma JTO CLINICAL AND RESEARCH REPORTS 2024 Apr;5(4):(沖塩協一)
25. Kako J,Kajiwara K,Kobayashi M,Kanno Y,Morikawa M,Nakano K,Matsuda Y,Shimizu Y,Niino M,Suzuki M,Shimazu T Applicability of Nursing Support for Patients With Terminal Cancer and Their Families: A Delphi Study AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE 2024 Apr 5;42(2):145-154.(松田能宣)
26. Hasegawa T,Mori M,Yamaguchi T,Imai K,Matsuda Y,Maeda I,Hatano Y,Yokomichi N,Hamano J,Morita T Delirium Motor Subtypes and Severity of Physical Symptoms in Patients with Advanced Cancer in Inpatient Hospice/Palliative Care Units: A Multicenter Prospective Cohort Study Journal of Palliative Medicine 2024 Dec 5;(松田能宣)
27. Shimaya M,Inagaki Y,Arai T,Kawakami M,Takeuchi N,Sumikawa H,Shimizu S,Takimoto T,Inoue Y Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome Internal medicine 2024 May;63(10):1451-1457.(島矢未奈子)
28. Taniguchi Y,Arai T,Tsuji T,Sugimoto C,Tachibana K,Akira M,Inoue Y Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases Journal of Thoracic Disease 2024 May;16(5):3129-+.(谷口善彦)
29. Hoshida Y,Tsujii A,Ohshima S,Saeki Y,Yagita M,Miyamura T,Katayama M,Kawasaki T,Hiramatsu Y,Oshima H,Murayama T,Higa S,Kuraoka K,Hirano F,Ichikawa K,Kurosawa M,Suzuki H,Chiba N,Sugiyama T,Minami Y,Niino H,Ihata A,Saito I,Mitsuo A,Maejima T,Kawashima A,Tsutani H,Takahi K,Kasai T,Shinno Y,Tachiyama Y,Teramoto N,Taguchi K,Naito S,Yoshizawa S,Ito M,Suenaga Y,Mori S,Nagakura S,Yoshikawa N,Nomoto M,Ueda A,Nagaoka S,Tsuura Y,Setoguchi K,Sugii S,Abe A,Sugaya T,Sugahara H,Fujita S,Kunugiza Y,Iizuka N,Yoshihara R,Yabe H,Fujisaki T,Morii E,Takeshita M,Sato M,Saito K,Matsui K,Tomita Y,Furukawa H,Tohma S Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative Disorders Arthritis & rheumatology 2024 Jun 10;76(6):869-881.(笠井孝彦)
30. Kurahara Y,Shimatani Y Laryngitis Caused by Mycobacterium abscessus Subspecies massiliense Infection JMA Journal 2024 Jul 16;7(3):441-442.(倉原優)
31. Amano K,Okamura S,Matsuda Y,Baracos VE,Mori N,Miura T,Tatara R,Kessoku T,Tagami K,Otani H,Mori M,Taniyama T,Nakajima N,Nakanishi E,Kako J,Morita T,Miyashita M Associations of nutrition impact symptoms with depression in patients with advanced cancer Supportive Care in Cancer 2024 Jul;32(7):(松田能宣)
32. Sakurai T,Kanou T,Funaki S,Fukui E,Kimura T,Ose N,Inoue Y,Shintani Y Effect of mTOR inhibitors on the mortality and safety of patients with lymphangioleiomyomatosis on the lung transplantation waitlist: A retrospective cohort study Respiratory investigation 2024 Jul;62(4):657-662.(井上義一)
33. Inoue Y,Kitamura H,Okamoto M,Ogura T,Nishioka Y,Kuwana M,Taniguchi A,Ito T,Rohr KB,Suda T The effect of nintedanib on health-related quality of life in Japanese patients with progressive fibrosing interstitial lung diseases: A subset analysis of the INBUILD trial Respiratory investigation 2024 Jul;62(4):589-596.(井上義一)
34. Tsuboi M,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Tokito T,Mio T,Adachi H,Kozuki T,Sone T,Seike M,Toyooka S,Kitagawa H,Koto R,Yamazaki S,Horinouchi H Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study Thoracic cancer 2024 Jul;15(20):1541-1552.(安宅信二)
35. Hasegawa T,Okuyama T,Uemura T,Matsuda Y,Otani H,Shimizu J,Horio Y,Watanabe N,Yamaguchi T,Fukuda S,Oguri T,Maeno K,Inagaki Y,Nosaki K,Fukumitsu K,Akechi T Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer Supportive Care in Cancer 2024 Jul;32(7):(稲垣雄士)
36. Miwa S,Mori M,Yamaguchi T,Suzuki K,Matsuda Y,Matsunuma R,Watanabe H,Ikari T,Matsumoto Y,Imai K,Yokomichi N,Yamauchi T,Okamoto S,Inoue S,Inoue A,Morita T,Satomi E,Japanese Dyspnea Relief Investigators Potential Efficacy of Midazolam as Second-Line Treatment for Terminal Dyspnea in Patients with Cancer: Secondary Analysis of a Multicenter Prospective Cohort Study Palliative Medicine Reports 2024 Jul 1;5(1):225-233.(松田能宣)
37. Kojima K,Samejima H,Iguchi T,Tokunaga T,Okishio K,Yoon H Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer Scientific reports 2024 Jul 4;14(1):(小島健介)
38. Enomoto T,Shirai Y,Takeda Y,Edahiro R,Shichino S,Nakayama M,Takahashi-Itoh M,Noda Y,Adachi Y,Kawasaki T,Koba T,Futami Y,Yaga M,Hosono Y,Yoshimura H,Amiya S,Hara R,Yamamoto M,Nakatsubo D,Suga Y,Naito M,Masuhiro K,Hirata H,Iwahori K,Nagatomo I,Miyake K,Koyama S,Fukushima K,Shiroyama T,Naito Y,Futami S,Natsume-Kitatani Y,Nojima S,Yanagawa M,Shintani Y,Nogami-Itoh M,Mizuguchi K,Adachi J,Tomonaga T,Inoue Y,Kumanogoh A SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosis Takatoshi Enomoto, ... , Yoshikazu Inoue, Atsushi Kumanogoh JCI Insight 2024 Jul 10;9(11):(井上義一)
39. Nakano K,Kanno Y,Kajiwara K,Kobayashi M,Morikawa M,Matsuda Y,Shimizu Y,Shimazu T,Kako J Nursing Support for Constipation in Patients with Cancer: A Scoping Review Journal of Palliative Medicine 2024 Jul 29;28(1):115-122.(松田能宣)
40. Kurahara Y,Tanaka Y,Kobayashi T,Yoshida S,Tsuyuguchi K Efficacy of an oscillating positive expiratory pressure device in patients with Mycobacterium avium complex pulmonary disease Journal of Infection and Chemotherapy 2024 Aug;30(8):780-784.(倉原優)
41. Hamamoto Y,Kawamura M,Uchida H,Hiramatsu K,Katori C,Asai H,Shimizu S,Egawa S,Yoshida K The Histological Detection of Ulcerative Colitis Using a No-Code Artificial Intelligence Model International Journal of Surgical Pathology 2024 Aug;32(5):890-894.(清水重喜)
42. Shimizu M,Maeda I,Kessoku T,Ishiki H,Matsuura T,Hiratsuka Y,Matsuda Y,Hasegawa T,Imai K,Oyamada S,Satomi E The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study Supportive Care in Cancer 2024 Aug;32(8):(松田能宣)
43. Yaga M,Hasegawa K,Ikeda S,Matsubara M,Hiroshima T,Kimura T,Shirai Y,Tansri W,Uehara H,Tachikawa M,Okairi Y,Sone M,Mori H,Kogue Y,Akamine H,Okuzaki D,Kawagishi K,Kawanaka S,Yamato H,Takeuchi Y,Okura E,Kanzaki R,Okami J,Nakamichi I,Nakane S,Kobayashi A,Iwazawa T,Tokunaga T,Yokouchi H,Yano Y,Uchida J,Mori M,Komuta K,Tachi T,Kuroda H,Kijima N,Kishima H,Ichii M,Futami S,Naito Y,Shiroyama T,Miyake K,Koyama S,Hirata H,Takeda Y,Funaki S,Shintani Y,Kumanogoh A,Hosen N CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy Scientific reports 2024 Aug 2;14(1):(德永俊照)
44. Taniguchi Y, Tamiya A, Osuga M, Harada D, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status BMC Pulmonary Medicine 2024 Aug 24;24(24):407.(谷口善彦)
45. Takimoto T, Sumikawa H, Inoue Y, Arai T. Auto-Fluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome: Negative Auto-Fluorescence Sign. American Journal of Respiratory and Critical Care Medicine 2024 Sep;210(5):665-668.(滝本宜之)
46. Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T, Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R, Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy Thoracic Cancer 2024 Sep;15(26):1882-1888.(露口一成)
47. Tanaka Y,Kobayashi T,Shimizu S,Kurahara Y Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug Internal medicine 2024 Sep;63(18):2587-2588.(田中悠也)
48. Ueno M,Egashira R,Hashisako M,Fujimoto K,Fukuda T,Hayashida Y,Sumikawa H,Tominaga J,Tanaka T,Terasaki Y,Fukuoka J,Nishioka Y,Aoki T,Gabata T,Hatabu H,Johkoh T Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence Japanese Journal of Radiology 2024 Sep;42(9):993-1002.(澄川裕充)
49. Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer. Lung Cancer 2024 Sep;195107917.(田宮朗裕)
50. Moda M,Sumikawa H,Shintani R,Takeuchi N,Kagawa T,Takimoto T,Arai T Natural history of indolent-anti-synthetase syndrome-associated interstitial lung disease Respiratory investigation 2024 Sep;62(5):872-878.(茂田光弘)
51. Matsumoto K,Yamamoto Y,Shiroyama T,Kuge T,Mori M,Tamiya M,Kinehara Y,Tamiya A,Suzuki H,Tobita S,Ueno K,Niki T,Nagatomo I,Takeda Y,Kumanogoh A Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study Targeted Oncology 2024 Sep;19(5):757-767.(田宮朗裕)
52. Takimoto T,Sumikawa H,Inoue Y,Arai T Autofluorescence Imaging of Bronchoscopy in Mounier-Kuhn Syndrome Negative Autofluorescence Sign American Journal of Respiratory and Critical Care Medicine 2024 Sep 1;210(5):665-668.(滝本宜之)
53. Enomoto N,Nakai S,Yazawa S,Mochizuka Y,Fukada A,Tanaka Y,Naoi H,Inoue Y,Yasui H,Karayama M,Suzuki Y,Hozumi H,Furuhashi K,Toyoshima M,Kono M,Imokawa S,Fujii M,Akamatsu T,Koshimizu N,Yokomura K,Matsuda H,Kaida Y,Nakamura Y,Shirai M,Mori K,Masuda M,Fujisawa T,Inui N,Sugiura H,Sumikawa H,Kitani M,Tabata K,Ogawa N,Suda T CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study Respiratory Research 2024 Sep 28;25(1):(澄川裕充)
54. Kojima K,Samejima H,Okishio K,Tokunaga T,Yoon H,Atagi S Impact of the number of dissected lymph nodes on machine learning-based prediction of postoperative lung cancer recurrence: a single-hospital retrospective cohort study BMJ Open Respiratory Research 2024 Sep 28;11(1):(小島健介)
55. Kubo K,Sakuraya M,Sugimoto H,Takahashi N,Kano K,Yoshimura J,Egi M,Kondo Y Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis Critical Care Medicine 2024 Oct;52(10):e522-e534.(杉本裕史)
56. Shibaki R,Fujimoto D,Miyauchi E,Tsukita Y,Nakachi I,Arai D,Sakata Y,Shingu N,Shimokawa T,Kijima T,Tamiya M,Kawana S,Harai S,Saito G,Sato Y,Yokoyama T,Sakata S,Taniguchi Y,Hata A,Matsumoto H,Yamaguchi T,Yamamoto N Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial Lung Cancer 2024 Oct;196(谷口善彦)
57. Tsukaguchi A,Tamiya A,Fukuda S,Iwahashi Y,Kanaoka K,Tanaka Y,Inagaki Y,Taniguchi Y,Nakao K,Kagawa T,Matsuda Y,Okishio K Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer Anticancer Research 2024 Oct;44(10):4517-4524.(塚口晃洋)
58. Sumikawa H,Johkoh T,Egashira R,Sugiura H,Sugimoto C,Tanaka T,Nakamura M,Kuriu A,Tomiyama N,Fujisawa T,Nakamura Y,Suda T Variability of radiological and clinical features in cases with usual interstitial pneumonia without honeycombing European Journal of Radiology 2024 Oct;179(澄川裕充)
59. Wijsenbeek MS,Swigris JJ,Spagnolo P,Kolb M,Kreuter M,Nunes H,Stansen W,Rohr KB,Inoue Y,INBUILD Trial Investigators Worsening dyspnoea as a predictor of progression of pulmonary fibrosis European Respiratory Journal 2024 Oct;64(4):(井上義一)
60. Kako J,Morikawa M,Kajiwara K,Kobayashi M,Kanno Y,Nakano K,Matsuda Y Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan Palliative Medicine Reports 2024 Oct 1;5(1):440-444.(松田能宣)
61. Yamaguchi T,Matsuda Y,Watanabe H,Kako J,Kasahara Y,Goya S,Kohara H,Mori M,Nakayama T,JSPM Treatment Recommendation for Dyspnea in Patients with Advanced Disease: Revised Clinical Guidelines from the Japanese Society for Palliative Medicine Journal of Palliative Medicine 2024 Oct 1;27(10):1404-1414.(松田能宣)
62. Kajiwara K,Kobayashi M,Nakano K,Kanno Y,Morikawa M,Matsuda Y,Kako J Use of Nursing Support Among Nurses for Caregiver Burden in Family Caregivers of Terminally Ill Patients with Cancer in Palliative Care Units in Japan: Multisite Cross-Sectional Study Palliative Medicine Reports 2024 Oct 1;5(1):425-429.(松田能宣)
63. Sakura K,Kuroyama M,Shintani Y,Funaki S,Atagi S,Kadota Y,Kuribayashi K,Kijima T,Nakano T,Nakajima T,Sasai M,Okumura M,Kaneda Y Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial Cancer Immunology Immunotherapy 2024 Oct 3;73(12):(安宅信二)
64. Hasuo H,Ishiki H,Matsuda Y,Matsuoka H,Kosugi K,Xing M,Akiyama Y,Matsumoto Y,Ishikawa H Trigger point injections for myofascial pain in terminal cancer: a randomized trial Pain Medicine 2024 Oct 12;26(1):14-21.(松田能宣)
65. Kondoh Y,Furukawa T,Hozumi H,Suda T,Egashira R,Jokoh T,Fukuoka J,Kuwana M,Teramachi R,Fujisawa T,Hasegawa Y,Ogura T,Miyazaki Y,Oyama S,Teramukai S,Horiguchi G,Naito A,Inoue Y,Ichikado K,Bando M,Tomioka H,Nishioka Y,Chiba H,Ebina M,Nakanishi Y,Satoh K,Shiratori Y,Hashimoto N,Ishii M The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis BMC pulmonary medicine 2024 Oct 14;24(1):(井上義一)
66. Drent M, Russell AM, Saketkoo LA, Spagnolo P, Veltkamp M, Wells AU; representatives of the sarcoidosis community: Nicole Goh, Anne Holland, Johann Hochreiter, Selene Kock, Karolien Verheyen, Johan Verbraecken, André Cantin, Ashley Gillson, Nathan Hambly, Martin Kolb, Elisabeth Bendstrup, Anna Leistiko, Janne Møller, Riitta Kaarteenaho, Bruno Crestani, Dominique Israël-Biet, Fleur Cohen Aubart, Hilario Nunes, Dominique Valeyre, Francesco Bonella, Katharina Buschulte, Ulrich Costabel, Peter Kortsen, Michael Kreuter, Peter Luedike, Bernd Quadder, Renate Braune, Dirk Skowasch, Katerina Antoniou, Demosthenes Bouros, Athena Gogali, George A Margaritopoulos, Despoina Papakosta, Spyros A Papiris, Effrosyni D Manali, Argyris Tzouvelekis, Vasilios Tzilas, Aditya Agrawal, Surender Kashyap, Vijay Narain Tyagi, Desai Unnati, Atefeh Abedini, Sean Phelan, Elena Bargagli, Francesco Cinetto, Marco Confalonieri, Paola Confalonieri, Sergio Harari, Fabrizio Luppi, Filippo Martone, Anna Palmieri, Paola Rottoli, Francesco Salton, Ricardo Scarpa, Claudio Tana, Sara Tomassetti, Arata Azuma, Naoki Inui, Yutaro Nakamura, Yoshikazu Inoue, Yoshinori Tanino, Noorul Afidza Muhammad, Frouke van Beek, Lenze den Boer, Karin Boomars, Paul Bresser, Laura Claessen, Marjon Elfferich, Roel Erckens, Sanne van Helmondt, Bekir Karakaya, Jan C Grutters, Elske Hoitsma, Károly Illy, Tim L Jansen, Vivienne Kahlmann, Chris Knoet, Ingrid Korenromp, Ton Lenssen, Karen Maassen Vd Brinkdrs, Johannes Jurgen Mager, Rik Marcellis, Jelle Miedema, Trudeke Möller, Linda A A Moonen, Karen Moor, Rémy L M Mostard, Willemien Nienhuis, Esther Nossent, Michelle Paulus, Rudolf Ponds, George Nossent, Marian Quanjel, Felix Rottenberg, Jonathan S O van de Sande, Ruud Segers, Shalini D Soechitram, AnneLoes van Staa, Bert Strookappe, Martin Swaans, Leon van den Toorn, Marjo J T van de Ven, Mareye Voortman, Adriane Dore Marie Vorselaars, Lenneke Vente, Petal A Wijnen, Marlies Wijsenbeek, Jolanda De Vries, Arthur van Zanten, Michael Durheim, Øystein Rasch-Halvorsen, Anders Tøndell, Anna Dubaniewicz, Wojciech Piotrowski, Bartlomiej Roter, Carlos Robalo Cordeiro, Tiago Alfaro, Irina Strambu, Alexander Vizel, Rafael Cano, Eva Balcells, Diego Castillo, Joel Francesqui, Juan Mañá, Maria Molina, Inigo Ojanguren, Jose Antonio Rodriguez Portal, Jacobo Sellares, Elizabeth Arkema, Pernilla Darlington, Per Eldhagen, Katinka Elfström, Johan Grunewald, Susanna Kullberg, Natalia V Rivera, Marios Rossides, Joanna Werner, Irem Dincer, Gülcan Koç, Canan Yucesan, Ozlem Ozdemir Kumbasar, Surinder Birring, Jeanette Boyd, Leo Casimo, Christopher Huntley, Vasileios Kouranos, Jaqui Newton, Lisa Spencer, Mark Spears, Paula Barreras, Yvette Cozier, Elliott Crouser, Logan Harper, W Ennis James, Lisa Maier, Shu-Yi Liao, Adam Morgenthau, Ogugua Ndili Obi, Divya Patel, Frank Rivera, Milton D Rossman, Michelle Sharp, Maggie Sharma, Jonas C Schupp, Barney J Stern, Nadera Sweiss, Jinny Tavee, Daniel Zank, Galyna Gumeniuk, Volodymyr Gavrysyuk, Levgeniia Merenkova. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis Lancet Respiratory Medicine 2024 Nov;12(11):848-851.(井上義一)
67. Kako J,Kobayashi M,Matsuda Y,Inoue S,Tanimukai H,Wada S,Hasegawa T Nonpharmacological Intervention for Delirium in Patients With Cancer: A Scoping Review Journal of Pain and Symptom Management 2024 Nov;68(5):(松田能宣)
68. Kanaoka K,Arai T,Takimoto T,Moda M,Shintani R,Ryuge M,Takeuchi N,Kagawa T,Tachibana K,Inoue Y,Sumikawa H,Takeda M,Shimizu S Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective study Respiratory investigation 2024 Nov;62(6):1161-1167.(金岡賢輔)
69. Kawachi H,Tamiya M,Oya Y,Saito G,Taniguchi Y,Matsumoto H,Sato Y,Otsuki T,Suzuki H,Fukuda Y,Tanaka S,Tsukita Y,Uchida J,Sakata Y,Nakatani Y,Shibaki R,Arai D,Okada A,Hara S,Takayama K,Nishino K Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005) Clinical Lung Cancer 2024 Nov;25(7):643-652.(谷口善彦)
70. Yoshida S,Tsuyuguchi K,Kobayashi T,Kurahara Y,Shimatani Y,Arai T Reassessment of the relevance between microbiological macrolide-induced resistance and diagnosis and treatment outcome of Mycobacterium abscessus-related pulmonary disease Respiratory Investigation 2024 Nov;62(6):1142-1148.(𠮷田志緒美)
71. Shimoda M,Tanaka Y,Ohe T,Ishiguro T,Suzuki A,Kurahara Y,Shimatani Y,Matsushima H,Kusano K,Ohta H,Yanagisawa S,Kozu Y,Yui T,Igarashi S,Kimizuka Y,Honda K,Otani S,Chiba S,Xu DJ,Mitsui M,Waseda Y,Ishii H Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase Respiratory Investigation 2024 Nov;62(6):963-969.(倉原優)
72. Amano K,Koshimoto S,Okamura S,Sakaguchi T,Arakawa S,Matsuda Y,Tokoro A,Takeuchi T,Satomi E,Wada T,Wada M,Yamada T,Mori N Association of Systemic Inflammation with Dietary Intake, Nutrition Impact Symptoms, and Eating-Related Distress Among Patients with Advanced Cancer Healthcare 2024 Dec;12(24):(松田能宣)
73. Nii T, Fujiwara K, Kobayashi T, Hagiwara E, Fukushima K, Morimoto K, Tsuyuguchi K, Ogura T, Kida H. Serodiagnosis of M. abscessus species pulmonary disease using anti-glycopeptidolipid-core IgA antibody. IJTLD OPEN 2024 Dec;1(12):575－577.(露口一成)
74. Kurahara Y, Tanaka Y, Kobayashi T, Yoshida S, Tsuyuguchi K Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease Journal of Infection and Chemotherapy 2025 Jan;31(1):102441.(倉原優)
75. Sugisaka J,Fujimoto D,Tamiya M,Hata A,Matsumoto H,Yokoyama T,Taniguchi Y,Uchida J,Sato Y,Kijima T,Tanaka H,Furuya N,Masuda T,Sakata Y,Miyauchi E,Saito G,Miura S,Yamaguchi T,Daga H,Sakata S,Yamamoto N,Akamatsu H Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study Lung Cancer 2025 Jan;199(谷口善彦)
76. Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01. Clinical Lung Cancer 2025 Jan;26(1):1-8.(田宮朗裕)
77. Horinouchi H,Murakami H,Harada H,Sobue T,Kato T,Atagi S,Kozuki T,Tokito T,Oizumi S,Seike M,Ohashi K,Mio T,Sone T,Iwao C,Iwane T,Koto R,Tsuboi M Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study Lung Cancer 2025 Jan;199(安宅信二)
78. Arai T,Inoue Y,Akasaka K,Masunaga A,Fujita M,Yamaguchi E,Saigusa M,Murakami K,Kurahara Y,Tsuyuguchi K,Suzuki T,Miyazaki Y,Bando M,Suda T Severity and prognosis of COVID-19 complicated by autoimmune pulmonary alveolar proteinosis Respiratory investigation 2025 Jan;63(1):20-26.(新井徹)
79. Akapelwa M, Kapalamula T, Moonga L, Bwalya P, Solo E, Chizimu J, Thapa J, Hayashida K, Hang’ombe B, Munyeme M, Tamaru A, Wada W, Yoshida S, Kodera T, Kawase M, Gordon S, Yamada K, Nakajima C, Suzuki Y Development of a multiplex Loop-Mediated Isothermal Amplification (LAMP) method for differential detection of Mycobacterium bovis and Mycobacterium tuberculosis by dipstick DNA chromatography Microbiology Spectrum 2025 Jan 3;(𠮷田志緒美)
80. Inoue Y,Ogura T,Azuma A,Kondoh Y,Homma S,Muraishi K,Ikeda R,Ochiai K,Sugiyama Y,Nukiwa T Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy 2025 Feb;42(2):1075-1093.(井上義一)
81. Takashi Nishihara, Hideo Ishikawa, Kazunari Tsuyuguchi, Shoichi Fukuda, Hiromitsu Sumikawa Reevaluating the Role of Bronchoscopy Prior to Bronchial Artery Embolization in Non-Intubated Patients with Hemoptysis due to Bronchiectasis and Chronic Pulmonary Infection Chest Pulmonary 2025 Mar;online first(西原昂)
82. Takimoto T,Takeuchi N,Inoue Y,Arai T Vocal cord palsy in interstitial lung disease: Involvement of architectural distortion by pleuroparenchymal fibroelastosis PULMONOLOGY 2024 Sep 30;30(5):488-491.(滝本宜之)
83. Ozawa Y,Koh Y,Hase T,Chibana K,Kaira K,Okishio K,Ichihara E,Murakami S,Shimokawa M,Yamamoto N Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Therapeutic Advances in Medical Oncology 2024;16(沖塩協一)
84. Kurahara Y,Shimatani Y,Ryuge M,Tsuyuguchi K Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae Internal medicine 2024;63(6):879-880.(倉原優)
85. Kurahara Y Tuberculous Bronchostenosis Manifesting as the "CT Angiogram Sign" Internal medicine 2024;63(18):2581-2582.(倉原優)
和文原著・著書等
1. 田中 悠也, 倉原 優．病気のはなし 結核検査と技術2024;52(2): 124-128.
2. 松田 能宣．不安と呼吸困難呼吸器内科2024;45(4):422～426.
3. 倉原 優．論文視点 コロナ肺炎の後遺症3年後も3分の1に病変残存Medical Tribune2024;57(8):3.
4. 田中 悠也, 倉原 優, 嶋谷 泰明, 小林 岳彦, 吉田 志緒美, 松本 錦之介, 露口 一成．肺非結核性抗酸菌症から菌交代し肺結核を発症した症例の検討結核2024;99(3):154.
5. 倉原 優．膿性痰で分類されていたCOPD増悪の基準に下剋上J-IDEO2024;8(3):504-505.
6. 倉原 優．ポケット呼吸器診療2024シーニュ2024;
7. 露口一成．非結核性抗酸菌症の微生物学的検査の実際呼吸器内科2024;45(6):566-570.
8. 松田能宣．パニック発作
今夜からもう困らない！夜の症状緩和 南江堂2024;128～135.
9. 松田能宣．第Ⅳ章特定集団への緩和ケア 6慢性呼吸器疾患専門家をめざす人のための緩和医療学 南江堂2024;333～336.
10. 松田能宣．非がん慢性呼吸器疾患：エビデンスアップデート医学のあゆみ2024;289(10):771～775.
11. 倉原 優．エアロゾルと抗酸菌感染症呼吸器内科2024;45(6):623-628.
12. 倉原 優．なぜ右の横隔膜が弱いのか？J-IDEO2024;8(4):684-685.
13. 新井 徹．肺胞蛋白症呼吸器内科診療の掟2024;502～510.
14. 田中 悠也, 倉原 優パルスオキシメータ呼吸器ジャーナル2024;72376-378.
15. 田中 悠也, 倉原 優高高度における呼吸生理呼吸器ジャーナル2024;72392-394.
16. 田中 悠也, 倉原 優「Happy hypoxia」について再考する呼吸器ジャーナル2024;72491-493.
17. 倉原 優、森本耕三「世界気管支拡張症デー」広く病気の認知をJ-BREATH2024;(133):11.
18. 倉原 優．肺NTM症とエストロゲン枯渇J-IDEO2024;8(5):834-836.
19. 和田佐保、松田能宣、井上真一郎、角甲純、谷向仁【ガイドラインを実践できる,エビデンスと臨床のギャップが埋まる 向精神薬のエビデンスベースドプラクティス】(第2章)いまはこうする!ガイドラインのトリセツ せん妄(解説)薬事2024;66(14):2623-2629.
20. 松田能宣．【精神科医として関わるがん治療関連精神症状】進行がんにおける低活動型せん妄の診断と対応(解説)臨床精神薬理2024;27(10):1013-1021.
21. 𠮷田志緒美, 山本剛, 石井良和, 御手洗聡抗酸菌検査のアンケート調査2022における結果報告 結核2024;99(6):163-172.
22. 田中 悠也, 倉原 優喘息・COPD鑑別が難しい症例の問診・身体所見の実臨床でのコツ（検査に重きを置いて）. jmedmook94 今日の診療に活かせる喘息・COPD ポイント解説.今日の診療に活かせる 喘息・COPDポイント解説2024;
23. 倉原 優．慢性肺アスペルギルス症とイサブコナゾールJ-IDEO2024;8(6):982-984.
24. 露口一成．肺結核症最新ガイドラインに基づく呼吸器疾患診療指針2024;
25. 井上義一．リンパ脈管筋腫症最新ガイドラインに基づく呼吸器疾患診療指針 第６版2024;
26. 新井 徹．間質性肺炎の診断と地域連携Medical Practice2025;42(1):50～54.
27. 倉原 優．見逃したくない縦隔炎J-IDEO2025;9(1):62-64.
28. 𠮷田志緒美．検査材料抗酸菌検査ガイド20252025;31-36.
29. 井上義一．肺胞蛋白症呼吸器疾患最新の治療2025-20262025;
30. 蓮尾英明、松岡弘道、松田能宣緩和ケアにおける悩ましい感情のひも解き方Difficult Patient2025;
31. 倉原 優．「肺NTM症の診断基準」の改訂J-IDEO2025;9(2):282-283.
32. 𠮷田志緒美．病理組織標本で抗酸菌が観察されていますが，培養で発育しないと言われました．どのような抗酸菌を想定し，追加対応はどのようにすればよいでしょうか？臨床検査2025増大号 「さっと読めてぱっとわかる！感染症診断メモ」2025;69(4):